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ABSTRACT 
 
SMALL FUNCTIONAL GROUPS PRESENTED ON PEPTIDE NANOFIBERS 
FOR DETERMINING FATE OF RAT MESENCHYMAL STEM CELLS 
Öncay Yaşa 
M.S. in Materials Science and Nanotechnology 
Supervisor: Assist. Prof. Dr. Ayşe Begüm Tekinay  
December, 2014 
 
 
 Glycosaminoglycans (GAGs) are negatively-charged, unbranched 
polysaccharides that play important roles in various biological processes and are vital 
for the regeneration of damaged tissues. Like other natural extracellular matrix 
components, glycosaminoglycans and proteoglycans show considerable variation in 
local concentration and chemical composition depending on tissue type. They are 
found in various connective tissues, including bone, cartilage and fat, and display 
strong water-binding capacity due to their negative charges. Mechanical characters of 
GAGs are heavily influenced by the degree and pattern of sulfation, which may 
greatly alter their viscoelasticity and physiological functions. Variations in GAG 
sulfation patterns are created principally through extracellular matrix modeling. Due 
to their extracellular matrix-organizing abilities, glycosaminoglycans are promising 
biomacromolecules for the design of new bioactive materials for tissue engineering 
and tissue reconstruction applications. In this study, we functionalized peptide 
amphiphile molecules with carboxylate and sulfonate groups to develop nanofibrous 
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networks displaying a range of chemical patterns, and evaluated the effect of the 
chemical groups over the differentiation fate of rat mesenchymal stem cells. We 
demonstrate that higher sulfonate-to-glucose ratios are associated with adipogenesis, 
while higher carboxylate-to-glucose ratios resulted in chondrogenic and osteogenic 
differentiation of the rat mesenchymal stem cells. 
 
 
Keywords: Peptide nanofibers, extracellular matrix, glycosaminoglycans, 
biomimetic, mesenchymal stem cells. 
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ÖZET 
 
PEPTİT NANOFİBERLER ÜZERİNDE SUNULAN KÜÇÜK FONKSİYONEL 
GRUPLARIN RAT MEZENKİMAL KÖK HÜCRELERİ KADERİNİN 
BELİRLENMESİ İÇİN KULLANILMASI 
Öncay Yaşa 
Malzeme Bilimi ve Nanoteknoloji Programı, Yüksek Lisans 
Tez Yöneticisi: Yrd. Doç. Dr. Ayşe Begüm Tekinay 
Aralık, 2014 
 
 
 Glikozaminoglikanlar çeşitli biyolojik olaylarda ve zarar görmüş dokuların 
yenilenmesinde önemli roller oynayan negatif yüklü, dallanmamış polisakkaritlerdir. 
Diğer doğal hücre dışı matris elemanları gibi, glikozaminoglikanlar ve 
proteoglikanlar da dokunun tipine göre yerel konsantrasyon ve kimyasal 
kompozisyon olarak dikkate değer değişiklikler göstermektedirler. Kemik, kıkırdak 
ve yağ olmak üzere çeşitli bağ dokularda yer alırlar ve negatif yüklerinden dolayı 
güçlü su tutma özellikleri vardır. Sülfatlanma dereceleri ve motifleri 
glikozaminoglikanların mekanik özelliklerini etkileyip, viskoelastik ve fizyolojik 
fonksiyonlarını önemli derecede değiştirmektedir. Glikozaminoglikanların 
sülfatlanma motiflerindeki farklılıklar birincil olarak hücre dışı matris modelleme 
yöntemlerinden kaynaklanmaktadır. Hücre dışı matrisi organize edebilme 
özelliklerinden dolayı, glikozaminoglikanlar doku mühendisliği ve doku yenilenmesi 
uygulamalarında kullanılabilecek yeni biyoaktif malzemelerin geliştirilmesinde umut 
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vaat eden biyomakromoleküllerdir. Bu çalışmada, nanoipliksi yapıda ve farklı 
derecelerde kimyasal gruplar içeren ağlar geliştirebilmek adına peptit amfifil 
molekülleri karboksilat ve sülfonat gruplarıyla fonksiyonlandırılmış, ve elde edilen 
farklı derecelerde kimyasal gruplar içeren nanoipliksi iskelelerin rat mezenkimal kök 
hücrelerinde hücre farklılaşmasına olan etkileri araştırılmıştır. Yüksek sülfonat/ 
glikoz oranının yağ doku farklılaşmasıyla, yüksek karboksilat/glikoz oranının ise 
kıkırdak doku farklılaşmasıyla bağlantılı olduğu rat mezenşim kök hücrelerinde 
gösterilmiştir. 
 
 
Anahtar Kelimeler: Peptit nanofiberler, hücrelerarası iskele, glikozaminoglikanlar, 
biyomimetik, mezenkimal kök hücreler 
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INTRODUCTION 
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1.1 AN OVERVIEW OF REGENERATIVE MEDICINE 
 
 Regenerative medicine researches aim to assist the natural tissue regeneration 
process, and employ a variety of approaches to repair, renew or replace tissues or 
organs that have lost their functionality due to traumatic injury, disease, age or 
hereditary defects 
1
. The human body is a complex system, and its maintenance 
mechanisms include natural repair processes that operate at molecular, cellular and 
systemic levels to continuously regenerate lost tissue in healthy individuals. 
However, the body’s natural capacity for regeneration may not be enough in cases of 
severe injury or chronic disease, necessitating external assistance to fully restore the 
functions of the damaged tissue. Regenerative medicine studies deal with the 
organizational complexity and functional diversity of the cells and their surroundings 
to recover and regenerate tissues following traumatic injury. Its success, therefore, 
depends on our ability to understand the cellular and molecular mechanisms of 
regeneration, and to transfer this information to facilitate the functional regeneration 
of damaged tissues with limited capacity for renewal. Three main approaches are 
used in regenerative medicine studies in order to regenerate damaged tissues or 
organs. These approaches are: (1) differentiated cell (progenitor cell) or stem cell 
transplantation either alone or as part of a biomaterial 
2-3
, (2) artificial tissue 
implantation 
4
 and (3) induction of the regeneration by using chemicals at the sites of 
injuries 
5
. These methods can be employed alone or in combination to overcome the 
engineering limitations of the bionic devices and the donor shortage inherent to 
organ transplants 
6
.  
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 The effectiveness of regenerative medicine hinges on its ability to mimic the 
microenvironment normally experienced by cells in their native tissues. This 
microenvironment typically contains at least one of these features: 
 
1. The presence of the requisite bio-signals for cell attachment and migration;  
2. The retention and presentation of biochemical factors; 
3. A porous environment for the adequate diffusion of nutrients, and waste; and 
4. Mechanical characteristics, such as rigidity or elasticity, that are naturally 
experienced by each cell type 
7
. 
 
1.1.1 PROGENITOR CELL OR STEM CELL TRANSPLANTATION 
 
 Cell transplantation is an attractive alternative to whole organ transplantation 
because (1) it allows early intervention in diseases, (2) it reduces the 
immunogenecity of transplantation and the risk of organ rejection, and (3) it 
eliminates the risk of proper donor finding. Cells used in transplantation studies 
should be easy to access and propagate, be pluripotent and not subject to immuno-
rejection. Progenitor cells and stem cells show these properties, and therefore can be 
used in cell transplantation studies either alone or part of a biomaterial. There are two 
main types of stem cells, embryonic stem cells and adult stem cells. Embryonic stem 
cells are totipotent cells, i.e. they can differentiate into all three embryonic germ 
layers. Adult stem cells are multipotent cells, and have more limited differentiation 
potentials compared to embryonic stem cells. They can differentiate into mesodermal 
and non-mesodermal cell types 
8
. 
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1.1.2 ARTIFICIAL TISSUE IMPLANTATION 
 
 Artificial tissue implantation involves the development of biomimetic devices 
or functionalized platforms that can be used to replace areas of damaged tissue and 
provide a suitable environment for the survival and regeneration of the remaining 
cells. Various artificial tissue transplants have been developed for the replacement of 
several tissue types, using methods such as hydrogels or 3D bio-printing. For 
example, it was shown that a mixture of human liver precursor cells and two other 
cell types can form 3D structures called “liver buds”, which were able to form 
functional connections with natural blood vessels and perform liver-specific 
functions in vivo 
9
. In another study, a complex 3D architecture with designed 
patterns was created by using pressure activated micro-syringe equipped with a fine-
bore exit needle and used to constitute implantable bioartificial organs. It was 
demonstrated that cells remain viable and continue their biological functions in this 
platform because the microchannels present in the system provide an easy access to 
nutrients and facilitate the removal of waste materials 
10
.   
 
1.1.3 INDUCTION OF REGENERATION BY INTRODUCING CHEMICALS 
INTO THE SITE OF INJURY 
 
 Small molecules can be used to induce regeneration directly at the site of 
injury. This method has several advantages compared to artificial tissue implantation 
and cell transplantation. First, these chemicals have physicochemically well-defined 
structures and can be synthesized in large quantities with little batch-to-batch 
5 
 
variation. In addition, most of these chemicals have the ability to penetrate the cells 
and modulate intracellular processes. Finally, being small molecules, they are 
relatively non-immunogenic compared to other regeneration strategies 
11
. 
 It is well-demonstrated that small chemicals with the ability to target specific 
signaling pathways and/or proteins can be used for the manipulation of cell fate, state 
and function 
12
. There are various strategies for efficient directed differentiation of 
the cells as shown in Figure 1.1. To illustrate; Noggin is a BMP4 inhibitor and 
SB431542 is a TGFβ receptor inhibitor, and the inhibition of BMP pathway and 
TGFβ pathway at the same time by using these molecules increased the efficiency of 
neural differentiation of a monolayer culture of human embryonic stem cells 
13
. 
Pumorphamine which is an adenine derivative is another example for the small 
molecules used in regenerative medicine applications. It is used as an inducer of 
osteoblast formation from multipotent mesenchymal progenitor cells and lineage-
committed preosteoblasts 
14
. 
 The in vivo potential of small chemicals is also well-established. For instance, 
the 1,2-isoxazoles were shown to repair damaged heart tissue after infarction, 
activating a cardiac program in the Notch-activated epicardium-derived progenitor 
cells 
15
. Finally, in another in vivo study, a compound named as P7C3 was shown to 
improve the survival of newly formed neurons from apoptotic cell death and promote 
neurogenesis in the subgranular zone of the hippocampal dentate gyrus, but did not 
affect neural stem cell differentiation 
16
.   
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Figure 1.1 Chemical strategies for inducing differentiation. Differentiation in vitro is 
typically carried out in a stepwise manner that recapitulates normal embryonic 
development. Several strategies have been developed to increase the efficiency of 
differentiation towards a specific lineage: (a) inhibiting stem cell self-renewal by 
small molecules to accelerate or enhance the differentiation process; (b) directing 
cells into specific cell types by a combination of small molecules that induce desired 
lineage-specific mechanisms and inhibit the activity of pathways and genes that lead 
to the induction of undesired cell types; (c) promoting progenitor cell expansion by 
small molecules to generate a large population of intermediate cells for various 
applications; and (d) maturing terminally differentiated cells by small molecules to 
generate desired functional cells. ESC, embryonic stem cell; iPSC, induced 
pluripotent stem cell 
12
. 
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1.2 MESENCHYMAL STEM CELLS IN REGENERATIVE MEDICINE 
 
 Mesenchymal stem cells (MSCs), also known as multipotent marrow stromal 
cells or mesenchymal stromal cells, are stromal cells that have the ability to self-
renew and/or differentiate into mesodermal (bone, adipose and cartilage) and non-
mesodermal lineages (Figure 2.1) 
17-20
. MSCs can be distinguished from other cell 
types due to their four intrinsic characteristics. (1) They show plastic adherent 
properties under standard culture conditions. (2) They express the surface markers 
CD73, CD90 and CD105. (3) They have a fibroblast-like morphology. (4) They lack 
the expression of the surface markers CD45, CD34, CD14 or CD11b, CD79a and 
HLA-DR 
21
. 
 
1.2.1 THE DISCOVERY OF MESENCHYMAL STEM CELLS 
 
 The presence of stem cells for non-hematopoietic cells in bone marrow was 
first recognized 130 years ago, by the observations of the German pathologist 
Cohnheim. In his research, Cohnheim suggested the possibility that bone marrow 
may be the source of fibroblasts, and that these fibroblasts initiate collagen fiber 
deposition as part of the normal wound repair process 
22
. 
 Starting with the work of Friedenstein and colleagues, it was known that bone 
marrow contains cells that can differentiate into other mesenchymal cells, as well as 
developing into fibroblastic colony forming cells 
23
. Ever since, these findings were 
also confirmed by numerous scientists and it was also demonstrated that these cells 
can also be found in the human bone marrow 
24
. 
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Figure 1.2 Mesenchymal stem cells can give rise to osteocytes, hypertrophic 
chondrocytes and adipocytes, or self-renew to produce identical cells that may later 
differentiate toward lineages that form the skeleton and bone marrow stroma. Trans-
differentiation of MSCs into other non-mesodermal cell types has been also reported 
in vitro but remains controversial in vivo 
25
. 
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1.2.2 ISOLATION OF MESENCHYMAL STEM CELLS 
 
 Mesenchymal stem cells can be isolated from many different sites of the body 
including the superior iliac crest of the pelvis in humans, the tibial and femoral 
marrow compartments and the thoracic and lumbar spine 
26-29
. MSCs can be isolated 
and enriched with standard cell culture methods in which samples are fractionated on 
a density gradient and plating the isolated cells at densities from 1.0 x 10
4
 to 0.4 x 
10
6
 cells/cm
2
 
30
. 
 
1.2.3 DIFFERENTIATION OF MESENCHYMAL STEM CELLS 
 
 It was demonstrated in many studies that MSCs can differentiate into bone, 
cartilage and fat tissues 
31-33
. β-glycerophosphate, ascorbic acid-2-phosphate, 
dexamethasone and fetal bovine serum are required for the activation of osteogenic 
differentiation. When cultured with these supplements, mesenchymal stem cells 
increase their alkaline phosphatase activities and deposit a calcium-rich mineralized 
extracellular matrix, in addition to showing osteoblastic morphology. Chondrogenic 
differentiation of mesenchymal stem cells requires a three-dimensional culture 
configuration, a serum free nutrient medium and a member of the TFG-β 
superfamily. In the presence of these factors, MSCs upregulate the expression of 
cartilage specific extracellular matrix components and start to lose their fibroblastic 
morphology. Adipogenic differentiation can be initiated by culturing MSCs in a 
monolayer culture in the presence of isobutylmethylxanthine, and confirmed visually 
by the formation of large lipid vacuoles in differentiating cells. Peroxisome 
10 
 
proliferator-activated receptor-gamma and fatty acid synthetase also play important 
roles in the induction of adipogenic differentiation in MSCs 
34
. 
 
1.3 EXTRACELLULAR MATRIX AND ITS COMPONENTS 
 
 Extracellular matrix (ECM) is the material that surrounds the cells. It is 
paramount for cell-to-cell communication and the maintenance of tissue integrity. 
The ECM is highly complex and consists of a great variety of proteins, primarily in 
the form of proteoglycans, glycoproteins and long nanofibers. Natural extracellular 
matrix components provide structural and biochemical support for cells, and direct 
cellular behaviors such as adhesion, migration, proliferation, and differentiation. The 
extracellular matrix microenvironment therefore has an indispensable role for the 
survival and the regeneration of the cells. The composition, topology and 
physicochemical characteristics of the extracellular matrix show differences 
according to cell and tissue types, wound- and disease-states, and age. In addition to 
these, the ECM has a very dynamic structure even within a single type of tissue, as it 
is constantly being remodeled by enzymatic and non-enzymatic processes 
35
. 
Extracellular matrix receptors, such as integrins and syndecans, take roles in the 
adhesion of the cells 
36-37
. The adhesion of the cells to the ECM triggers cytoskeletal 
changes and can facilitate the migration of these cells through the ECM 
38
. 
Collagens, elastins, fibronectins and laminins are the main fibrous extracellular 
matrix proteins 
39
. From these fibrous proteins, collagen is the most abundant one 
found in the extracellular matrix and it gives tensile strength, helps cell adhesion and 
support migration and chemotaxis 
40
. Collagens are defined by the triple helical 
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organization of component pro-α-chains that is formed as a result of the glycine 
amino acid being used in every third residue. There are now 28 known collagen types 
41
. Fibronectin takes roles in extracellular matrix organization, cell attachment and 
function 
42
. Fibronectin also has important functions in cell migration during 
embryonic development, tumor metastasis and cardiovascular disease 
43
.  Mechanical 
and biochemical changes in the extracellular matrix are perceived and acted upon by 
the cells through the crosstalk between integrins and the actin cytoskeleton 
44
. 
 
1.4 NATURAL GLYCOSAMINOGLYCANS AND THEIR ROLES IN TISSUE 
REGENERATION 
 
 Glycosaminoglycans (GAGs) are highly polar, negatively charged, 
unbranched polysaccharides which play important roles in various biological 
processes, and are vital for the regeneration of damaged tissues. They have extremely 
heterogeneous and complex structures due to degree of substitution and positioning 
of sulfate/sulfonate and acetyl groups 
45
. GAGs are mainly composed of repeating 
disaccharide units (Figure 1). The repeating disaccharide unit always contains an 
amino sugar; either N-acetylglucosamine or N-acetylgalactosamine, along with a 
uronic acid, usually D-glucuronic or L-iduronic acid 
46
. GAGs can be classified into 
four basic groups according to their repeating disaccharide structures and functions 
in the body. These four basic groups are: (1) Heparin/Heparan sulfate, (2) 
Chondroitin sulfate/Dermatan sulfate, (3) Keratan sulfate, and (4) Hyaluronic 
acid/Hyaluronan 
47
. Except for hyaluronan, they contain sulfate/sulfonate groups, 
form proteoglycans by substituting protein cores, and are synthesized in the 
12 
 
endoplasmic reticulum and Golgi bodies 
48
. GAGs have diverse intracellular and 
extracellular actions, and play crucial roles in different biological processes (Table 
1) including growth, proliferation and differentiation of the cells, regeneration of 
nerve, cartilage and bone tissues, angiogenesis, and tumor metastasis through 
specific interactions with growth factors, growth factor receptors, extracellular 
matrix proteins, and other chemokines 
49-54
. 
 
 
 
 
Figure 1.3 Chemical representations of the disaccharide units of 
glycosaminoglycans. (A) Chondroitin 4-sulfate, (B) Chondroitin 6-sulfate, (C) 
Dermatan sulfate, (D) Keratan sulfate, (E) Heparin, and (F) Hyaluronan. 
 
 Hyaluronan (HA), which is composed of alternating units of β-1,4-linked D-
glucuronic acid-β-1,3-N-acetyl-D-glucosamine, is the only non-sulfated 
glycosaminoglycan 
55
. Unlike other glycosaminoglycans, it is synthesized in the 
plasma membrane and its primary structure does not contain a peptide component 
48
. 
It especially forms the extracellular matrix of soft connective tissues, and interactions 
between hyaluronan receptor and extracellular polysaccharides have effects on 
13 
 
locomotion and cell migration 
56
. HA also has important biological functions in 
wound healing and remodeling, and serves to initiate inflammatory responses, 
maintain structural cell integrity and promote recovery from tissue injuries 
57
. 
 Chondroitin sulfate (CS) is composed of β-1,3-linked D-glucuronic acid-β-
1,4-N-acetyl-D-galactosamine. CS is a sulfated glycosaminoglycan commonly found 
in the cartilage extracellular matrix, where it serves to increase the resistance of this 
tissue against frictional and compressive stress 
58-60
. The CS disaccharides are 
sulfated on either C-4 or C-6 position of the N-acetyl-D-galactosamine residues and 
classified according to their sulfation patterns 
61
. Besides cartilage extracellular 
matrix, it is also the major element of the brain extracellular matrix and takes roles in 
plasticity, neural development, and regeneration. In adults, chondroitin sulfate 
proteoglycans also play roles in learning and memory processes 
62
. 
 Dermatan sulfate (DS) is another natural and sulfated glycosaminoglycan. DS 
is composed of β-1,3-linked L-iduronic acid-β-1,4-N-acetyl-D-galactosamine units 
and is also known as chondroitin sulfate B 
63
. In the cornea, it plays a crucial role in 
optical clarity by regulating fibril spacing 
64
. It also has roles in bone metabolism in 
pathological conditions by regulating osteoclast formation through interaction with 
receptor activator of NF-κB ligand and inhibition of signal transduction in osteoclast 
progenitor cells 
65
. DS can selectively inhibit thrombin without interfering with 
platelets. Therefore, it can also be used as anticoagulant for patients with acute renal 
failure after a major cardiovascular surgery 
66
. 
 Heparan sulfate (HS) is composed of alternating units of α-D-glucosamine 
and uronic acid, either β-D-glucuronic acid or α-L-iduronic acid, and linked by 1,4 
glycosidic bond. The α-D-glucosamine can be either N-sulfated or N-acetylated 67. 
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Bearing one of the highest natural complexities among glycosaminoglycans, HS 
performs a wide range of biological activities including roles in blood coating, 
angiogenesis, and the protection of proteins from degradation 
68
. It also takes role in 
regulation of bone morphogenetic proteins' activities and induction of 
morphogenesis. For instance, cell surface heparan sulfate proteoglycans can 
intercede BMP-2 internalization and it was shown that these heparan sulfate 
supramolecules lead to transdifferentiation of C2C12 myoblasts into osteoblasts 
through direct regulation of BMP-2 activities 
69
. 
 Keratan sulfate (KS) is composed of β-1,3-linked D-galactose-β-1,4-N-acetyl-
D-glucosamine units and sulfated on C-6 of either or both hexose moieties 
70
. KS is 
associated with a vast variety of biological functions in different tissue types and 
developmental stages. It is mainly found in cornea, cartilage, and brain. It is the 
major GAG in cornea and takes role in corneal hydration and maintenance of ECM 
structure 
71
. Due to its highly hydrated nature, KS suppresses cartilage damage in 
joints and exogenous KS application can be used for treatment of inflammatory 
arthritis 
72
. KS is also synthesized in central nervous system and takes an important 
role in modulating axonal growth after spinal cord injury 
73
. 
 In the extracellular matrices of all mammalian tissues, GAGs are found 
covalently attached to proteins, and classified as proteoglycans except for hyaluronan 
74
. Proteoglycans are classified according to their GAG composition, localization and 
core proteins. Their molecular sizes, abundances, and sulfation and acetylation 
patterns change based on tissue types and developmental stages. Proteoglycans can 
be separated into three main families which are small leucine-rich proteoglycans, 
modular proteoglycans and cell-surface proteoglycans 
75
. Small leucine-rich 
15 
 
proteoglycans take roles in various signaling pathways and regulation of 
inflammatory response reactions. To illustrate, they can bind to and activate 
epidermal growth factor receptor, insulin-like growth factor 1 receptor, and TGF-β 76-
77
. Modular proteoglycans take roles in mainly cell adhesion, migration and 
proliferation. Cell-surface proteoglycans can act as co-receptors facilitating ligand 
encounters with signaling receptors 
35
. 
 
Table 1.1 The localization and primary functions of the natural glycosaminoglycans 
in the body.  
 
Glycosaminoglycan Localization Functions References 
Heparin/Heparan 
sulfate 
basement 
membranes, 
mast cells, 
lung, liver and 
skin  
takes roles in the allergic and 
inflammatory reactions driven by 
mast cells 
functions as an anticoagulant 
primarily through activation of AT-
mediated inhibition of blood 
coagulation factors 
78-79
 
Chondroitin 
sulfate/Dermatan 
sulfate 
cartilage, 
bone, skin, 
blood vessels, 
heart valves, 
tendons, lung 
provides resistance to compression 
take roles in coagulation, infection, 
wound repair, and fibrosis 
60,63
 
Keratan sulfate 
cornea, bone, 
cartilage 
takes roles in the cellular 
recognition of protein ligands, 
axonal guidance, cell motility and 
in embryo implantation 
70
 
Hyaluronic 
acid/Hyaluronan 
synovial fluid, 
articular 
cartilage, skin  
have functions in joints 
lubricate and protect cartilage 
surfaces 
prevent capillary growth 
80
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1.5 PEPTIDE AMPHIPHILE MOLECULES AND THEIR USE IN 
REGENERATIVE MEDICINE 
 
 Peptide amphiphiles (PAs) are peptide-based molecules that can self-
assemble into high-aspect ratio nanofibers. A typical peptide amphiphile 
macromolecule consists of four main regions. The hydrophobic domain that consists 
of a long alkyl tail forms the first region. A short peptide sequence which takes role 
in the formation of intermolecular hydrogen bonds forms the second region. The 
third region is formed from charged amino acids to enhance solubility of the 
macromolecule in water and to design pH and salt-responsive nanostructures and 
networks. The fourth region contains bioactive signals that is usually designed by 
mimicking epitopes and used for providing special signals that take roles in 
nanostructure-cell interactions and differentiation of the cells 
81
. 
 The amphiphilic nature of the peptide amphiphile molecules comes from the 
incorporation of a hydrophobic alkyl tail after the peptide sequence. This 
hydrophobic alkyl tail that forms the first region of the macromolecules as previously 
mentioned allows the presentation of peptide signals specifically on the periphery of 
self-assembled nanostructures. The hydrophobic tails can also be adjusted by using 
different alkyl chain lengths or by using different hydrophobic components 
82
. The 
short peptide sequence that forms the second region of the macromolecules usually 
consists of hydrophobic amino acids. This short peptide sequence allows formation 
of intermolecular hydrogen bonds generally in the form of β-sheets and leads for the 
presentation of bioactive signals on the nanofiber surface at a high density. Charged 
amino acids that form the third region of a peptide amphiphile molecule come after 
17 
 
the short peptide sequences and their number and identity determine the solubility of 
the peptide amphiphile molecules under physiological conditions. The bioactive 
peptide sequence formed by mimicking various epitopes constitutes the last and the 
most important region of the peptide amphiphile molecules if they will be used in a 
biological study. This region may consist of different biological signals such as one 
that promotes cell adhesion 
83-84
 or one that generates a pronounced therapeutic effect 
85-86
. 
 Peptide amphiphile molecules were first presented approximately a decade 
ago as a regenerative tool for bio-mineralization. In this study, it was shown that 
peptide nanofibers with phosphoserine residues self-assembled into nanofibers that 
can nucleate thin hydroxyapatite crystals on their surfaces in vitro as observed in 
bone formation 
87
. The importance of phosphoserine residue for nucleation of 
hydroxyapatite was also proved in vivo using an orthotopic rat femoral critical-size 
defect model. In this study performed by Mata et al., the combined effects of 
fibronectin epitope RGDS and the phosphoserine residues on bone regeneration were 
determined by the analysis of hydroxyapatite nucleation, and it was concluded that 
the presence of phosphoserine residues on the peptide nanofibers enhances formation 
of biomimetic bone crystals 
88
. 
 Recently, various peptide amphiphile nanofibers that contain bioactive signals 
have been used to mimic natural sulfated glycosaminoglycans and to constitute a 
suitable microenvironment for the survival and differentiation of the osteogenic cells. 
In one study, a heparin-mimetic peptide amphiphile scaffold system was used to 
analyze osteogenic differentiation of Saos-2 cells. The BMP-2 binding capacity of 
these heparin-mimetic peptide scaffold was shown by using an ELISA based growth 
18 
 
factor binding assay. The nanofiber scaffold showed osteoinductive properties by 
stabilizing BMP-2 and providing a convenient microenvironment for bone 
regeneration with their sulfonate and carboxylate groups. These nanofiber networks 
also enhance the viability, proliferation and mineralization of the osteogenic cells by 
binding to BMP-2 
89
. 
 Ustun et al. used heparin mimetic PA macromolecule to analyze 
differentiation of chondroprogenitor ATDC5 cells. Heparin mimetic peptide scaffold 
was found to give both structural and functional assistance for the cells, causing 
rapid aggregation of the cells in insulin-free medium, which culminate in the 
formation of cartilage-like nodules. The sulfated glycosaminoglycan deposition was 
shown with Safranin-O staining, and the bioactive role of the nanofiber system was 
also revealed with qRT-PCR which was used to show expression levels of collagen II 
and aggrecan genes 
90
. 
 In a different study, the effect of heparin-mimetic PA on neurite outgrowth 
was analyzed in combination with laminin-derived PA. It was revealed that 
hydrogels composed of self-assembly of a laminin-derived PA and heparin mimetic 
PA increase the efficiency of the neurite outgrowth compared to laminin-derived PAs 
alone. It was also revealed that the inhibitory effect of chondroitin sulfate 
proteoglycans on the central nervous system can be overcome by using this scaffold 
91
. 
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1.6 MOTIVATION AND GOALS 
 
 Despite vast advancements in biology and its sub-disciplines, it is still not 
possible to fully mimic sophisticated biological materials in either form or function. 
As such, regenerative medicine often aims to partially replicate the effect of 
biological structures by identifying and utilizing functional regions that contain 
crucial biological signals. Peptide amphiphile macromolecules allow direct 
incorporation of these functional regions into their primary sequences. By using 
peptide amphiphile molecules, nanostructures with high aspect ratios, complex 
architectures and desired biochemical characteristics can be easily produced under 
physiological conditions. These peptide nanostructures can then be used in various 
regenerative medicine applications, where they are expected to enhance the natural 
regeneration process due to their resemblances to the native microenvironments of 
their target tissues.   
 It was previously shown that synthetic matrices containing small-molecule 
chemical functional groups can be used for controlled induction of differentiation to 
multiple mesenchymal stem cell lineages 
92
. In this study, peptide amphiphile 
molecules modified with different small functional groups were used to determine 
the effect of GAG composition on rat mesenchymal stem cell fate. Our hypothesis 
was that the functions of natural glycosaminoglycans can be mimicked using a 
combination of various small functional groups; and we tested this hypothesis under 
in vitro conditions by investigating the differentiation tendency of rat mesenchymal 
stem cells over functionalized bioactive nanofibrous networks towards mesodermal 
lineages. 
20 
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2.1 CHEMICALS AND SOLUTIONS 
 
Solid State Peptide Synthesis Reagents: 
 
 9-Fluorenylmethoxycarbonyl (Fmoc) and tert-butoxycarbonyl (Boc) 
protected amino acids except glyco amino acid, [4-[α-(2',4'-dimethoxyphenyl) Fmoc-
aminomethyl]phenoxy] acetamidonorleucyl-MBHA resin (Rink amide MBHA 
resin), Fmoc-Glu(OtBu)-Wang resin, and 2-(1H-Benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium hexafluoro-phosphate (HBTU) were purchased from 
NovaBiochem and ABCR. Fmoc-Ser[β-Glc(OAc)4]-OH was purchased from 
AAPPTec. N,N-diisopropylethylamine (DIEA) and lauric acid were purchased from 
Merck. Piperidine, acetic anhydride, dichloromethane (DCM), dimethylformamide 
(DMF), trifluoroacetic acid (TFA) and triisoproplysilane (TIS) were purchased form 
Sigma-Aldrich. The remaining chemicals were purchased from Fisher and/or Alfa 
Aesar; all chemicals were used as provided. Deionized water with a resistance of 18 
MΩ.cm (Millipore Milli-Q) was used in all experiments.  
 
Cell Culture Reagents: 
 
 Dulbecco’s Modified Eagle Medium (DMEM), Penicillin/Streptomycin (PS) 
antibiotic combination and Fetal Bovine Serum (FBS) were purchased from Gibco, 
Life Technologies. Alamar Blue was purchased from Invitrogen. BrdU (colorimetric) 
was purchased from Roche. Safranin-O, Oil Red-O and Alizarin Red-S were 
purchased from Sigma-Aldrich. 
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2.2 SYNTHESIS OF PEPTIDE AMPHIPHILE MOLECULES 
 
 Peptide amphiphile molecules were synthesized by using a standard solid 
phase peptide synthesis method with Rink amide MBHA resin or glutamic acid 
loaded Wang resin. GLC-PA [Lauryl-VVAGKS(Glc)-NH2], SO3-PA [Lauryl-
VVAGEK(p-sulfobenzoate)-NH2] and K-PA [Lauryl-VVAGK- NH2] were 
synthesized on Rink amide MBHA resin. E-PA [Lauryl-VVAGE] was synthesized 
on Fmoc-Glu-Wang resin. Prior to the first coupling reaction, the resins were swelled 
in DCM for 30 min and the solvent was exchanged to DMF, in which all remaining 
reactions were carried out. In the synthesis of every peptide amphiphile molecules, 
the solid state was washed three times with DMF, three times with DCM and finally 
again three times with DMF respectively between each step to remove unreacted 
chemicals. Each coupling reaction started with the removal of the Fmoc protecting 
group by using 20% (v/v) piperidine/dimethylformamide solution for 20 min. Amino 
acids were then prepared for the coupling reaction by dissolving in DMF and amino 
acid coupling reactions were performed by using 2 equivalents of amino acid, 1.95 
equivalents of HBTU and 3 equivalents of DIEA in 10 mL DMF for 2.5 h. At the end 
of each coupling step, the completeness of the coupling reaction was determined with 
Kaiser test. If the reaction was complete, the amino acid chain was exposed to 10% 
(v/v) acetic anhydride/dimethylformamide solution for 30 min in order to acetylate 
unreacted amine groups prior to the next coupling cycle. These steps were repeated 
until the desired amino acid sequences were obtained (Table 2.1). The lauric acid tail 
was then added in a similar fashion to the amino acid coupling reaction, except that 
the coupling time was 4 h. After the synthesis procedure, peptide cleavage from the 
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solid phase was carried out for 2 h at room temperature with 95% cleavage cocktail 
(95:2.5:2.5 TFA:TIS:ddH2O) and excess TFA and DCM were subsequently removed 
with rotary evaporator. The remaining peptide amphiphile solution was then 
precipitated using overnight incubation in ice cold diethyl ether at -20 °C. The 
solution was then centrifuged at 8000 rpm for 15 min to completely precipitate 
peptide amphiphile molecules; diethyl ether was then decanted and the remainder in 
the flask was evaporated, and the peptide amphiphile molecules were dissolved with 
ddH2O. Finally, the peptide amphiphile solution was frozen at -80 °C for 4 h, 
lyophilized for 3 days and stored at -20 °C. 
 
Table 2.1 Sequences, molecular weights, and charges of the synthesized peptide 
amphiphile molecules. 
 
Name Sequence 
Molecular 
Weight 
Charge 
GLC-PA Lauryl-VVAGKS(Glc)-Am 903.12 +1 
SO3-PA 
Lauryl-VVAGEK(p-
sulfobenzoate)-Am 
967.18 -2 
K-PA Lauryl-VVAGK-Am 653.90  +1 
E-PA Lauryl-VVAGE 655.82 -2 
 
2.3 CHARACTERIZATION OF THE SELF-ASSEMBLED PEPTIDE 
NANOSTRUCTURES 
 
 High Pressure Liquid Chromatography (HPLC) was used to purify the 
synthesized peptide amphiphile molecules, while Liquid Chromatography-Mass 
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Spectroscopy (LC-MS), Circular Dichroism (CD), Scanning Electron Microscopy 
(SEM) and Transmission Electron Microscopy (TEM) were used to perform 
chemical and mechanical characterizations of peptide amphiphile molecules. 
 
2.3.1 LIQUID CHROMATOGRAPHY-MASS SPECTROSCOPY 
 
 A quadruple time of flight (Q-TOF) mass spectrometer with electrospray 
ionization (ESI) source equipped with a reverse phase analytical high performance 
liquid chromatography was used to characterize the synthesized peptide amphiphile 
molecules. For the characterization of negatively and positively charged PA 
molecules, Agilent Zorbax Extend-C18 (2.1 x 50 mm) column and Zorbax SB-C8 
(4.6 x 100 mm) column were used as stationary phases respectively. A gradient of 
water (0.1% formic acid or 0.1% NH4OH) and acetonitrile (0.1% formic acid or 
0.1% NH4OH) was used as mobile phase during liquid chromatography. 
 
High Pressure Liquid Chromatography: 
 
 Reverse phase preparative HPLC equipped with either Zorbax Extend-C18 
(21.2 x 150 mm) column or Zorbax SB-C8 (21.2 x 150 mm) column as a stationary 
phase were used to purify negatively and positively charged PA molecules, 
respectively. A gradient of water (0.1% acetonitrile or 0.1% NH4OH) and acetonitrile 
(0.1% formic acid or 0.1% NH4OH) were used as a mobile phase during HPLC 
purification of the synthesized PA molecules. Furthermore; according to their 
synthesis purity, positively charged PA molecules were only treated with 0.1 M HCl 
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solution in dialysis bags, in which the remaining TFA removed through chloride ion 
exchange. 
 
2.3.2 CIRCULAR DICHROISM 
 
 Circular dichroism analyses were performed by using a J-815 Jasco 
spectrophotometer in the far ultra-violet region. PA molecules were prepared and 
used at a final concentration of 200 μM during all analysis. Quartz cuvette with 1 
mm pathlength was used for all measurements. Measurement parameters were 
selected as: digital integration time of 1 sec, band width of 1 nm, data pitch of 0.1 
nm, and with standard sensitivity. The scanning results were the average of three 
readings in a spectral range between 190 nm and 300 nm. Following scanning, 
ellipticity data obtained from the measurements were converted to molar ellipticity 
(with the unit degree.cm
2
.mole
-1
) using the following formula: 
 
[θ] = 
     θ
      
 
 
[θ]: Molar ellipticity, θ: Ellipticity, C: Concentration in Molar, l: Length in cm 
 
2.3.3 SCANNING ELECTRON MICROSCOPY 
 
 Scanning electron microscopy samples were prepared by mixing 10 mM Glc-
PA and 10 mM E-PA at 1:1 ratio, 10 mM Glc-PA and 10 mM SO3-PA at 1:1 ratio, 
10 mM Glc-PA, 10 mM SO3-PA and 10 mM E-PA at 2:1:1 ratio, and finally 10 mM 
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K-PA and 10 mM E-PA at 1:1 ratio to have overall negatively charged hydrogels. 
Hydrogels were placed onto silicon wafers and incubated for 30 minutes before 
applying serial ethanol dehydration protocol. Hydrogels were dehydrated 
sequentially in 20% (v/v), 40% (v/v), 60% (v/v), 80% (v/v) and absolute ethanol, and 
subsequently dried by using a critical point dryer (Tousimis, Autosamdri-815B, 
Series C critical point dryer). Finally, samples were coated with 5 nm Au/Pd and 
analyzed by using a SEM (SEM, FEI Quanta 200 FEG) with an ETD detector at high 
vacuum mode at 10 keV beam energy. 
 
2.3.4 TRANSMISSION ELECTRON MICROSCOPY 
 
 Lacey mesh ultrathin carbon coated copper grids were used for transmission 
electron microscopy analysis. TEM samples were prepared by mixing 2 mM Glc-PA 
and 2 mM E-PA at 1:1 ratio, 2 mM Glc-PA and 2 mM SO3-PA at 1:1 ratio, 2 mM 
Glc-PA, 2 mM SO3-PA and 2 mM E-PA at 2:1:1 ratio, and finally 2 mM K-PA and 2 
mM E-PA at 1:1 ratio to have overall negatively charged hydrogels. The upper parts 
of grids were dipped for 1 min into samples that were previously diluted 100 times 
with distilled water; the grids were then stained with 2 wt% uranyl acetate for 40 
seconds and kept in a fume hood until a dried film was obtained. Finally; samples 
were kept in a fume hood until a dried film was obtained, and analyzed by using a 
FEI Tecnai G2 F30 transmission electron microscope. STEM images were also 
obtained with a FEI Tecnai G2 F30 TEM working at HAADF mode. All TEM and 
STEM images were acquired at 300 kV. 
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2.4 PEPTIDE AMPHIPHILE NANOFIBER FORMATION 
 
 Peptide amphiphile nanofibers were formed by mixing different combinations 
of positively (Glc-PA and K-PA) and negatively (SO3-PA and E-PA) charged PA 
molecules at neutral pH. In this study, four different PA nanofiber network systems 
were used and these nanofiber networks were prepared by mixing: 1) 2 mM Glc-PA 
and 2 mM E-PA at a 1:1 ratio, 2) 2 mM Glc-PA and 2 mM SO3-PA at a 1:1 ratio, 3) 
2 mM Glc-PA, 2 mM SO3-PA and 2 mM E-PA at a 2:1:1 ratio, respectively, and 
finally 4) 2 mM K-PA and 2 mM E-PA at a 1:1 ratio. The overall charges of the PA 
nanofiber networks were negative. All peptide amphiphile solutions were sterilized 
for 30 min under UV light shortly after they were prepared. Before the formation of 
nanofiber networks, pH of the peptide amphiphile solutions were checked by using 
pH-indicator strips and adjusted to neutral pH with NaOH or HCl. Finally, the 
solutions were sonicated for 30 min and mixed as above mentioned.  
 
2.5 CELL CULTURE 
 
 Cell culture experiments were performed by using rat mesenchymal stem 
cells. Cells were incubated at 37 °C in a humidified atmosphere supplied with 5% 
CO2. Cell maintenance was done in low glucose DMEM (Dulbecco’s modified 
eagle’s medium) supplemented with 10% (v/v) Fetal Bovine Serum (FBS) and 1% 
(v/v) Penicillin/Streptomycin (PS). Cell culture was performed in 75 cm
2
 flasks and 
cells were seeded in these flasks as 3 x 10
3
 cells/cm
2
. Cell medium was replenished 
every 3 days and the cells were used in experiments or subcultured when they 
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reached ~90% confluency. Osteogenic differentiation medium was used in 
mineralization experiments including Alizarin Red-S staining and alkaline 
phosphatase activity assay. The growth medium of cells was changed to osteogenic 
medium after the cells reached ~90% confluency. Osteogenic medium contains low 
glucose DMEM, 10% (v/v) FBS and 1% (v/v) Penicillin/Streptomycin supplemented 
with 10 mM β-glycerophosphate, 50 μg/mL ascorbic acid and 10 nM 
dexamethasone. 
 In order to perform 2D cell culture experiments, well plates were coated with 
peptide amphiphile nanofiber networks which were formed as previously mentioned. 
Then, the well plates were incubated at 37 °C for 30 minutes and dried in a 
biological safety cabinet. After overnight drying, peptide coated well plates were 
additionally sterilized with ultraviolet light for 30 minutes and cells were seeded in 
different amounts according to the experiments. 
 
2.5.1 CELL VIABILITY AND PROLIFERATION 
 
 Cell viability and proliferation analyses were performed by seeding rMSCs 
onto PA-coated and uncoated wells (TCP). 96-well plates were used for all analyses 
and cells were seeded at a density of 5 x 10
3
 cells/well. rMSCs were seeded in low 
glucose DMEM supplemented with 10% (v/v) FBS and 1% (v/v) 
Penicillin/Streptomycin under conditions of 5% CO2 at 37 °C in a humidified 
chamber. 
 Biocompatibilities of peptide amphiphile nanofiber networks were evaluated 
by using Alamar Blue assay (Invitrogen) at 24 h. At the end of 24 h, medium was 
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discarded and cells were washed with phosphate buffered saline (PBS). Then, cells 
were incubated with 10% (v/v) Alamar Blue in serum free media for 4 h. Absorbance 
at 570/600 nm excitation/emission was measured with a microplate reader 
(Molecular Devices Spectramax M5). Absorbance values that were showing the 
viability of the cells were normalized to uncoated wells. 
 The proliferation of the rMSCs on peptide amphiphile nanofiber networks 
was evaluated by using BrdU (colorimetric) at 72 h. At the end of 70 h, medium was 
discarded and then cells were incubated with standard cell culture medium 
supplemented with 100 μM BrdU labeling solution for 2 h. At the end of this 
incubation period, BrdU incorporation assay was performed as follows. First, cells 
were fixed with FixDenat solution for 30 minutes. Then, anti-BrdU-POD working 
solution was added to the wells and cells were incubated for 90 minutes. After that, 
the wells were washed with washing solution and finally substrate solution was 
added into the wells and proliferation rates of the cells were quantified by measuring 
absorbance (370 nm with 492 nm reference wavelength) with a microplate reader 
(Molecular Devices Spectramax M5).  
 
2.5.2 ALIZARIN RED-S STAINING 
 
 Alizarin Red-S staining was performed by using 96-well plates that were PA-
coated and uncoated. Cells were seeded at a density of 5 x 10
3
 cells/well under 
conditions of 5% CO2 at 37 °C in a humidified chamber either in low glucose 
DMEM supplemented with 10% (v/v) FBS and 1% (v/v) Penicillin/Streptomycin or 
in osteogenic differentiation medium (low glucose DMEM, 10% (v/v) FBS and 1% 
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(v/v) Penicillin/Streptomycin supplemented with 10 mM β-glycerophosphate, 50 
μg/mL ascorbic acid and 10 nM dexamethasone). Calcium deposition was assessed 
by staining the wells and the cells with Alizarin Red-S reagent at the end of day 7 
and day 14 as previously described 
93
. Briefly, medium was discarded and cells were 
washed with 1 x PBS. Then, cells were fixed with ice cooled 70% (v/v) ethanol for 1 
h at room temperature. After the fixation step, cells were washed with ddH2O on a 
shaker for 15 min and then stained with 40 mM Alizarin Red-S solution (pH 4.2) for 
30 min at room temperature on a shaker. Finally, the Alizarin Red-S solution was 
discarded and the wells were washed with ddH2O 5 times to get rid of non-specific 
binding of the dye. The stained calcium nodules were observed under a light 
microscope and all images were acquired at a 10x magnification. After image taking, 
to quantify Alizarin Red-S staining, wells were destained by using 10% (w/v) 
cetylpyridinium chloride in 10 mM sodium phosphate for 15 min at room 
temperature and absorbance was read at 562 nm by using a microplate reader. 
 
2.5.3 SAFRANIN-O STAINING 
 
 Safranin-O staining was performed by using 96 well plates that were PA-
coated and uncoated. Cells were seeded at a density of 5 x 10
3
 cells/well in low 
glucose DMEM supplemented with 10% (v/v) FBS and 1% (v/v) 
Penicillin/Streptomycin under conditions of 5% CO2 at 37 °C in a humidified 
atmosphere. Sulfated glycosaminoglycan depositions were assessed by staining the 
wells with Safranin-O reagent at the end of day 7 and day 14. Briefly, the culture 
medium was discarded and cells were washed with 1x PBS. After washing step, cells 
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were fixed by using 10% (v/v) formalin in PBS for 15 min at room temperature. 
Then, the cells were again washed with 1x PBS and afterwards blocked with 1% 
(w/v) BSA/PBS for 30 min at room temperature. After blocking, cells were stained 
with 0.1% (w/v) Safranin O in 1% (v/v) acetic acid for 5 min at room temperature. 
Finally, the wells were extensively washed 3 times with 0.1% (v/v) acetic acid in 
PBS to remove unbound dye and stained glycosaminoglycan depositions were 
observed under a light microscope. All images were acquired at a 10x magnification. 
 
2.5.4 OIL RED-O STAINING 
 
 Oil Red-O staining was performed by using 96 well plates that were PA-
coated and uncoated. Cells were seeded at a density of 5 x 10
3
 cells/well in low 
glucose DMEM supplemented with 10% (v/v) FBS and 1% (v/v) 
Penicillin/Streptomycin under conditions of 5% CO2 at 37 °C in a humidified 
chamber. Lipid vacuoles were assessed by staining the wells with Oil Red-O reagent 
at the end of day 7 and day 14. Briefly, the culture medium was discarded and cells 
were washed with 1x PBS and then incubated with 10% (v/v) formalin in PBS for 10 
min at room temperature. After that, the cells were fixed by changing formalin with 
fresh formalin and incubating for additional 1 h at room temperature. Then, the cells 
were washed with ddH2O and incubated with 60% (v/v) isopropanol for 5 min at 
room temperature. In the next step, isopropanol was removed and wells were 
completely air dried. After that, the cells were stained with Oil Red-O working 
solution for 10 min at room temperature and washed 4 times with ddH2O. Finally, 
images were acquired under a light microscope at 10x magnification. For the 
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quantification of Oil Red-O staining, Oil Red-O dye was eluted by incubating the 
cells with absolute isopropanol for 10 min at room temperature with gentle shaking. 
After that, the absorbance was measured at 500 nm by using 100% isopropanol as a 
blank with  a microplate reader (Molecular Devices Spectramax M5). 
 
2.5.5 PROTEIN AND ALKALINE PHOSPHATASE ACTIVITY ASSAYS 
 
 Protein and alkaline phosphatase activity assays were performed by using 48-
well plates that were PA-coated and uncoated. Cells were seeded at a density of 20 x 
10
3
 cells/well in low glucose DMEM supplemented with 10% (v/v) FBS and 1% 
(v/v) Penicilin/Streptomycin under conditions of 5% CO2 at 37 °C in a humidified 
chamber. Briefly, cells were washed with 1x PBS prior to protein extraction 
experiment. Protein extraction experiment was briefly performed first by adding PEK 
(Protein Extraction Kit)/PIK (Protease Inhibitor Cocktail) at a 95:5 ratio onto the 
cells and incubating on a shaker for 30 min. Then, the cells were lysed by vortexing 
and protein containing solutions from each well were transferred into eppendorf 
tubes by pipetting. After that, protein samples were centrifuged at 14000 g at 4 °C 
for 10 min and supernatants that contain proteins were taken into new eppendorf 
tubes. Pierce
®
 BCA protein assay (Thermo Scientific) was performed to quantify 
protein amount obtained from the cells as described in manufacturer's protocol. 
Absorbance was determined at 562 nm by using a micro plate reader (Molecular 
Devices Spectramax M5). 
 For the analyses of alkaline phosphatase (ALP) activities of rMSCs seeded 
onto different peptide nanofiber networks, 50 μL of protein sample obtained from the 
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protein assay was incubated with 150 μL of p-nitrophenol phosphate substrate in a 
96-well plate for 30 min on a shaker. Serial dilutions of p-nitrophenol in 0.25 M 
NaOH were used as standards. Finally, optical density was determined at 405 nm 
wavelength by using a microplate reader. The alkaline phosphatase activity values 
were normalized to total protein amounts. 
 
2.5.6 QUANTITATIVE REAL-TIME GENE EXPRESSION ANALYSES 
 
 Quantitative real-time polymerase chain reaction (qRT-PCR) was used for 
determining the gene expression profiles of rMSCs. Total RNA was isolated from rat 
mesenchymal stem cell samples by using TRIzol (Invitrogen) reagent. Nanodrop 
2000 (Thermoscientific) was used to assess the yield and purity of the extracted 
RNA. Primer sequences were designed using Primer 3 software (Table 2.2). The 
reaction efficiencies of each primer set were evaluated with standard curve by using 
2-fold serial dilutions of total RNA. cDNA synthesis from RNA and qRT-PCR were 
performed by using SuperScript III Platinum SYBR Green One-Step qRT-PCR Kit 
(Invitrogen). The qRT-PCR reaction conditions were briefly as follows: 55 °C for 5 
min, 95 °C for 5 min and 40 cycles of 95 °C for 15 sec, X °C (where X is the 
annealing temperature of the primers, see below) for 30 sec, and 40 °C for 1 min, 
followed by a melting curve to confirm product specificity. For analysis of the 
expression data, primary gene expression data was normalized to the expression level 
of GAPDH. A comparative Ct method was used to analyze the results. Gene 
expression was normalized to GAPDH and TCP. The expression levels of six 
different genes were analyzed and quantified by using qRT-PCR. These genes were 
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runt-related transcription factor 2, collagen 1, transcription factor SOX-9, collagen 2, 
adiponectin and fatty acid binding protein 4. 
 
2.6 STATISTICAL ANALYSIS 
 
 All quantitative values are represented as means ± standard error of the mean 
(SEM). All experiments were performed with at least three replicates for each group 
and for at least three independent repeats. One-way analysis of variance (ANOVA) 
with Tukey post test or two-way analysis of variance (ANOVA) were used for 
statistical analysis and a P value of less than 0.05 was considered statistically 
significant. 
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Table 2.2 Primer sequences and annealing temperatures of runt-related transcription 
factor 2, collagen 1, transcription factor SOX-9, collagen 2, adiponectin and fatty 
acid binding protein 4 for rat mesenchymal stem cells. 
 
 
Gene Primer Sequence: Forward/Reverse 
Annealing 
Temperature (°C) 
Runt-related 
Transcription 
Factor 2 
(RUNX2) 
5'-GGACGAGGCAAGAGTTTCACT-3' 
5'-CCCTAAATCACTGAGGCGGT-3' 
59.5 °C 
Collagen 1 
(COL1) 
5'-GAATATGTATCACCAGACGCAGA-3' 
5'-GGACATCTGGGAAGCAAAGT-3' 
59.5 °C 
Transcription 
Factor SOX-9 
(SOX9) 
5′-CCACCCCGATTACAAGTACC-3′ 
5'-CAGCCACCTGGGACTCTAA-3' 
61.5 °C 
Collagen 2 
(COL2) 
5′-CGAGGTGACAAAGGAGAAGC-3′ 
5'-TCCCGGTCTTCATGGGACTA-3' 
55.0 °C 
Adiponectin 
(ADIPOQ) 
5'-AAGGGAGACGCAGGTGTTCTTGG-3' 
5'-ATGGGAACATTGGGGACAGTGAC-3' 
58.0 °C 
Fatty Acid 
Binding Protein 4 
(FABP4) 
5'-CCCAGATGACAGGAAAGTGAAGAGC-3' 
5'-CTTTCATGACACATTCCACCACCAG-3' 
59.0 °C 
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RESULTS AND DISCUSSIONS 
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3.1 SYNTHESIS AND CHARACTERIZATION OF PEPTIDE AMPHIPHILE 
MOLECULES 
 
 Four different peptide amphiphile molecules were designed and synthesized 
by using solid phase peptide synthesis protocol. These molecules were used to form 
nanofiber networks and to mimic natural extracellular matrix microenvironment. 
Peptide amphiphile molecules were designed as a composition of hydrophobic alkyl 
group, β-sheet driving group, and charged group. Lauric acid that was added at the 
end of peptide sequences gives a hydrophobic character to peptide amphiphile 
molecules and triggers hydrophobic collapse during self-assembly 
94
. Before the 
lauric acid hydrophobic tail, four non-polar amino acids were incorporated into the 
peptide sequences to constitute the β-sheet forming units of the peptide amphiphile 
molecules. Sequence of these non-polar amino acids that were used in all peptide 
amphiphile molecules was Val-Val-Ala-Gly (VVAG). The peptide amphiphile 
molecules that were used in this study to mimic glycosaminoglycan components of 
natural extracellular matrix were; Glc-PA [Lauryl-VVAGKS(Glc)-Am], K-PA 
[Lauryl-VVAGK-Am], E-PA [Lauryl-VVAGE] and SO3-PA [Lauryl-VVAGEK(p-
sulfobenzoate)-Am] (Figure 3.1). Glc-PA that contains one lysine and one serine, 
where a glucose group was attached to side chain of serine residue, after the β-sheet 
forming unit was designed to mimic the saccharide backbone of glycosaminoglycans. 
SO3-PA that contains one glutamic acid and one lysine, where a sulfonate group was 
attached to the side chain of lysine residue, after the β-sheet forming unit was 
designed to mimic sulfated glycosaminoglycans. E-PA which contains only one 
glutamic acid after VVAG sequence was designed to mimic unsulfated 
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glycosaminoglycans. K-PA which contains only one lysine after VVAG sequence (β-
sheet forming sequence) was designed and used as a counter positively charged 
peptide amphiphile molecule. Glc-PA and K-PA are positively charged at neutral pH 
whereas SO3-PA and E-PA are negatively charged. Glc-PA was used to form 
glycosaminoglycan mimetic hydrogels by adding negatively charged SO3-PA and/or 
E-PA molecules. Positively charged K-PA was mixed with negatively charged E-PA 
at neutral pH to form non-bioactive control group. By using these peptide amphiphile 
molecules, four different nanofiber network systems were formed and used in the 
experiments. These nanofiber network systems were Glc-PA/E-PA, Glc-PA/SO3-PA, 
Glc-PA/SO3-PA/E-PA and K-PA/E-PA (Figure 3.2). Glc-PA/E-PA network was 
used to mimic natural hyaluronan, which is a non-sulfated glycosaminoglycan and is 
widely distributed throughout connective and neural tissues. Glc-PA/SO3-PA and 
Glc-PA/SO3-PA/E-PA networks were used to mimic sulfated glycosaminoglycans. 
Glc-PA/SO3-PA nanofiber network system generally used to mimic heparan sulfate 
which contains one sulfate molecule in each saccharide residue. Glc-PA/SO3-PA/E-
PA nanofiber network system was generally used to mimic chondroitin sulfate and 
dermatan sulfate which contain one sulfate and one carboxyl molecules in each 
disaccharide residue. After the synthesis of peptide amphiphile molecules, they were 
purified according to their charges and molecular complexities by using high 
pressure liquid chromatography or 0.1 mM HCl (acid) treatment protocols. Then, the 
purity of synthesized molecules was checked again according to their charges by 
using liquid chromatography-mass spectroscopy. Finally, secondary structures of the 
nanofibers were analyzed by using circular dichroism, scanning electron microscopy 
and transmission electron microscopy.    
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Figure 3.1 Chemical representations of peptide amphiphile molecules. (A) Glc-PA 
[Lauryl-VVAGKS(Glc)-Am], (B) SO3-PA [Lauryl-VVAGEK(p-sulfo benzoate)-
Am], (C) E-PA [Lauryl-VVAGE], and (D) K-PA [Lauryl-VVAGK-Am].
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Figure 3.2 Self-assembled nanofiber network systems used in this study. The peptide nanofiber networks self-assemble when mixed with 
oppositely charged peptide amphiphiles and were modified to incorporate chemical groups found in natural glycosaminoglycans.
Glc-PA 
Lauryl-VVAGKS(Glc)-NH2 
SO3-PA 
Lauryl-VVAGEK(p-sulfo 
benzoate)-NH2 
K-PA 
Lauryl-VVAGK-NH2 
E-PA 
Lauryl-VVAGE 
Glc-PA/E-PA 
1/1 
High carboxylate-to-glucose 
ratio 
Glc-PA/SO3-PA 
1/1 
High sulfonate-to-glucose 
ratio 
Glc-PA/E-PA/SO3-PA 
2/1/1 
Medium sulfonate-to-glucose 
ratio 
K-PA/E-PA 
1/1 
No glucose or sulfonate 
residues 
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3.1.1 PURIFICATION OF THE PEPTIDE AMPHIPHILES WITH HIGH 
PRESSURE LIQUID CHROMATOGRAPHY 
  
 Reverse phase preparative HPLC equipped with either Zorbax Extend-C18 
(21.2 x 150 mm) column or Zorbax SB-C8 (21.2 x 150 mm) column as a stationary 
phase were used to purify negatively and positively charged peptide amphiphile 
molecules, respectively. A gradient of water (0.1% acetonitrile or 0.1% NH4OH) and 
acetonitrile (0.1% formic acid or 0.1% NH4OH) were used as a mobile phase during 
HPLC purification of the synthesized peptide amphiphile molecules. Negatively 
charged PA molecules were always purified with reverse phase HPLC to get rid of 
the unwanted molecules. However; according to their synthesis purity, positively 
charged PA molecules were sometimes only treated with 0.1 M HCl (acid) solution 
in dialysis bags in which the remaining TFA was exchanged with chloride ions and 
passed to outside through the pores of dialysis bags due to simple diffusion and 
therefore removed at the end. The purities of the synthesized peptide amphiphile 
molecules became more than 95% after HPLC and/or acid purifications and then 
these molecules used in characterization and cell culture experiments. 
 
3.1.2 ANALYSES OF PURITY AND SIZE OF PEPTIDE AMPHIPHILES 
 
 Q-TOF LC/MS was used to verify the purity of the synthesized peptide 
amphiphile molecules. Expected masses for the PA molecules are theoretically 
902.57 for Glc-PA, 966.51 for SO3-PA, 655.42 for E-PA and 653.48 for K-PA as 
shown in Table 2.1. Q-TOF LC/MS measurements were first performed subsequent 
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to synthesis of PA molecules to determine the completion and efficiency of the solid 
state peptide synthesis procedure and to decide which purification method will be 
used for further experiments. After performing the reverse phase preparative HPLC 
purification or acid treatment protocols as a purification method, Q-TOF LC/MS 
analyses were applied second time to indicate the final purity of the synthesized PA 
molecules. The elution time graphics which were obtained from Q-TOF LC/MS 
analyses as shown in Figure 3.3 gave information about the purity of the synthesized 
PA molecules. From Q-TOF LC/MS analyses, we obtained 903.59 for Glc-PA, 
965.47 for SO3-PA, 654.42 for E-PA and 654.48 for K-PA as shown in Figure 3.4. 
These results indicated that the solid phase peptide synthesis protocol was correctly 
applied for all synthesis reactions and therefore completely synthesized PA 
molecules were obtained at the end of the reactions.  
 
3.1.3 SECONDARY STRUCTURE DETERMINATION 
 
 Circular Dichroism (CD) analyses were performed to understand the 
secondary structure of PA molecules. CD measures the differential absorbance of 
left-handed and right-handed circularly polarized light which exhibited on optically 
active chiral molecules. In the case of PA molecules, the absorbance is provided by 
the amide group forming the peptide backbone and acting as a chromophore in the 
far UV region. The CD spectra of the PA hydrogels revealed a negative minimum at 
around 220 nm and a positive maximum at around 200 nm, which indicated the 
formation of β-sheet structure driven by the self-assembly of PAs in Glc-PA/E-PA, 
Glc-PA/SO3-PA, Glc-PA/SO3-PA/E-PA and K-PA/E-PA combinations (Figure 3.5). 
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Figure 3.3 HPLC chromatogram of purified: (A) Glc-PA, (B) SO3-PA, (C) E-PA, 
and (D) K-PA K molecule at 220 nm. 
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Figure 3.4 Electrospray ionization mass spectra of: (A) Glc-PA, (B) SO3-PA, (C) E-
PA, and (D) K-PA. 
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Figure 3.5 Circular dichroism (CD) spectra of peptide nanofibers used for the 
characterization of the secondary structures. CD results indicate that peptide 
amphiphile nanofibers show a characteristic β-sheet structure at physiological pH. 
 
3.1.4 MORPHOLOGICAL ANALYSIS OF PEPTIDE AMPHIPHILES 
 
 Scanning electron microscopy analyses were performed to characterize the 
self-assembly of peptide amphiphile molecules, the nanofiber formation and the 
morphology of the nanofiber networks. SEM analyses showed the formation of 
nanofibrous networks upon mixing oppositely charged peptide amphiphile molecules 
as Glc-PA/E-PA, Glc-PA/SO3-PA, Glc-PA/SO3-PA/E-PA and K-PA/E-PA 
combinations (Figure 3.6). The observed porous and nanofibrous network 
morphology of the PA hydrogels structurally resemble the native extracellular matrix 
found around the cells and therefore present a suitable microenvironment for the 
cells. 
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 Transmission electron microscopy analyses were performed to further verify 
the nanofiber formation and to analyze the individual nanofibers. TEM analyses 
revealed the formation of nanofibers upon charge neutralization of oppositely 
charged peptide amphiphile molecules as Glc-PA/E-PA, Glc-PA/SO3-PA, Glc-
PA/SO3-PA/E-PA and K-PA/E-PA combinations (Figure 3.7). Nanofibers were 
observed with 6 – 10 nm diameters and lengths up to a few microns. Moreover, 
bundling of the nanofibers was observed for K-PA/E-PA combination. These 
nanofibers resemble the fibrous macromolecules found in the native extracellular 
matrix of the cells. 
 
 
 
Figure 3.6 Characterization of the peptide amphiphile nanofiber networks by using 
scanning electron microscopy. (A) Glc-PA/E-PA, (B) Glc-PA/SO3-PA, (C) Glc-
PA/SO3-PA/E-PA and (D) K-PA/E-PA. 
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Figure 3.7 Characterization of the peptide amphiphile nanofiber networks by using 
transmission electron microscopy. (A) Glc-PA/E-PA, (B) Glc-PA/SO3-PA, (C) Glc-
PA/SO3-PA/E-PA and (D) K-PA/E-PA. 
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3.2 EFFECTS OF PEPTIDE NANOFIBER NETWORKS ON RAT 
MESENCHYMAL STEM CELLS 
 
 Cell culture experiments were performed in two different stages following 
each other. In the first stage, we examined the effects of peptide nanofiber networks 
on viability and proliferation of the rat mesenchymal stem cells by using alamar 
Blue® viability and BrdU (colorimetric) incorporation assays. According to the 
results of these analyses, we decided whether we can pass to the next stage or not. In 
the second stage, we examined qualitatively and quantitatively the differentiation of 
rat mesenchymal stem cells on peptide nanofiber networks by using Alizarin Red-S, 
Safranin-O and Oil Red-O staining, alkaline phosphatase activity assay and 
quantitative real-time polymerase chain reaction. 
 
3.2.1 THE DESIGN OF 2D CELL CULTURE EXPERIMENTS 
 
 Four different combinations of peptide amphiphile hydrogels were prepared 
and coated onto tissue culture plates by using Glc-PA, SO3-PA, K-PA and E-PA 
molecules as shown in Figure 3.2. Then, these hydrogels were used to determine the 
effects of chemical groups represented on peptide nanofibers on the cellular 
behaviors such as viability, proliferation and differentiation in cell culture. Glc-
PA/E-PA nanofiber networks were used to mimic non-sulfated glycosaminoglycan 
which is hyaluronan. Glc-PA/E-PA/SO3-PA nanofiber networks were used to mimic 
sulfated glycosaminoglycans which are chondroitin sulfate and dermatan sulfate. 
Glc-PA/SO3-PA nanofiber networks were used to mimic over-sulfated 
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glycosaminoglycans which are heparin and heparan sulfate. K-PA/E-PA nanofiber 
networks were used as a non-bioactive control group that only contained carboxylic 
acid residue over nanofiber networks. Uncoated tissue culture plates which lacked 
peptide coating were used as negative control. Rat mesenchymal stem cells that were 
at passage # 6 and had multi-lineage differentiation capacities were used in all in 
vitro experiments. 
 
3.2.2 BIOCOMPATIBILITY OF PEPTIDE NANOFIBER NETWORKS 
 
 AlamarBlue® (Invitrogen) was used to examine the effects of peptide 
nanofiber networks on the viability of rat mesenchymal stem cells. AlamarBlue® is 
an accurate cell viability indicator which uses the natural reducing power of the 
living cells. Resazurin, a non-toxic, non-fluorescent and cell permeable compound, is 
the active ingredient of alamarBlue®. Resazurin is continuously reduced to resorufin 
in viable cells and produces very bright red fluorescence upon this reduction reaction 
which is used for generating a quantitative measure of viability and cytotoxicity 
95-96
. 
 We checked the toxicological effects of Glc-PA/E-PA, Glc-PA/SO3-PA, Glc-
PA/SO3-PA/E-PA and K-PA/E-PA nanofiber networks on rat mesenchymal stem 
cells at 24 h. We used 96-well plates and seeded 5 x 10
3
 cells/well by using 
maintenance medium. At the end of 24 h, we incubated the cells for an additional 2 h 
with 10% (v/v) alamarBlue® and then measured the absorbance by using microplate 
reader, where the amount of absorbance corresponds to the cells' metabolic activity 
level. AlamarBlue® results showed that culturing on Glc-PA/E-PA, Glc-PA/SO3-PA, 
Glc-PA/SO3-PA/E-PA and K-PA/E-PA nanofiber networks did not alter the viability 
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of rat mesenchymal stem cells compared to uncoated tissue culture plate (Figure 
3.8). Cells showed average of 92.42%, 92.58%, 91.74% and 94.19% viability on 
Glc-PA/E-PA, Glc-PA/SO3-PA, Glc-PA/SO3-PA/E-PA and K-PA/E-PA nanofiber 
networks respectively when compared to uncoated tissue culture plate. These results 
demonstrated that peptide nanofiber systems are biocompatible with rat 
mesenchymal stem cells and they provide bio-friendly environments where cells can 
continue their life. 
 Overall, cellular viability was supported on bioactive peptide nanofiber 
networks and it was comparable with tissue culture plate. Therefore; we decided to 
use these nanofiber network systems in further experiments in which we checked the 
proliferation and differentiation of the cells over these peptide nanofiber networks. 
 
3.2.3 PROLIFERATION ANALYSIS OF RAT MESENCHYMAL STEM 
CELLS ON PEPTIDE NANOFIBER NETWORKS 
 
 Proliferation profiles of rat mesenchymal stem cells on peptide nanofiber 
networks were analyzed by using BrdU incorporation assay. 5-bromo-2-deoxyuridine 
(BrdU) is a synthetic uridine derivative and a structural analog of thymidine. It can 
be incorporated into DNA during the synthesis phase of the cell cycle as a substitute 
for thymidine, thereby serving as a marker for proliferation 
97
. BrdU can also be 
passed to daughter cells upon replication 
98
. 
 In this experiment, we checked the effects of Glc-PA/E-PA, Glc-PA/SO3-PA, 
Glc-PA/SO3-PA/E-PA and K-PA/E-PA nanofiber networks on proliferation of rat 
mesenchymal stem cells at 72 hours. We used 96-well plates and seeded 5 x 10
3
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cells/well by using maintenance medium. At the end of 70 h, we incubated the cells 
for an additional 2 h with BrdU labeling solution which contained 100 μM BrdU. 
After the incubation period, BrdU assay was applied as described in method part and 
the results were normalized to uncoated tissue culture plate. In this experiment, we 
did not observe a significant difference in proliferation of cells seeded on TCP and 
K-PA/E-PA nanofiber network. This result demonstrated that cells seeded on K-
PA/E-PA nanofiber network that contains no bioactive signal acted as cells seeded 
on tissue culture plate and continued their proliferation. However, we observed 
significant changes in the proliferation of cells seeded on Glc-PA/E-PA, Glc-
PA/SO3-PA and Glc-PA/SO3-PA/E-PA nanofiber networks when compared to TCP. 
These results showed that cells seeded on these nanofiber networks that contain 
biological signals decreased their proliferation and probably started to differentiate 
into other lineages. We also observed that proliferation of the cells seeded on Glc-
PA/SO3-PA nanofiber network that was formed by two bioactive signal containing 
PA macromolecules also decreased significantly compared to Glc-PA/E-PA 
nanofiber network which was formed by only one bioactive signal containing peptide 
amphiphile molecules. 
 Overall, Glc-PA and SO3-PA contain bioactive signals and nanofiber 
networks that were formed by using these peptide amphiphile molecules induced a 
decreased in the proliferation of rat mesenchymal stem cells perhaps due to 
differentiation signals according to the degree of sulfonate and carboxylate residues 
in the nanofibrous networks that the cells encountered. However, K-PA/E-PA 
nanofiber network which was used as a non-bioactive control did not affect the 
proliferation of the cells significantly. 
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Figure 3.8 Viability analyses of rat mesenchymal stem cells on different peptide 
nanofiber networks and uncoated tissue culture plate. AlamarBlue® was used to 
quantitatively determine the viability of rat mesenchymal stem cells at 24 h. One-
way ANOVA with Tukey post test (95% confidence interval) was applied for 
analyzing the results, and no significant difference was found between each groups. 
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Figure 3.9 Proliferation analyses of rat mesenchymal stem cells cultured with BrdU 
on different peptide nanofiber networks and uncoated tissue culture plate at day 3. 
One-way ANOVA with Tukey post test (95% confidence interval) was applied for 
analyzing the results and significant differences were expressed as (* p<0.05, ** 
p<0.01, *** p < 0.001). 
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3.3 INVESTIGATION OF THE DIFFERENTIATION OF RAT 
MESENCHYMAL STEM CELLS 
 
 Different experimental methods were used to analyze the differentiation of rat 
mesenchymal stem cells seeded onto various peptide nanofiber networks and 
uncoated tissue culture plate towards mesodermal lineages. These methods included 
histological staining with Safranin-O for analyzing deposition of sulfated 
glycosaminoglycans, Oil Red-O for investigating deposition of triglycerides and 
lipids and Alizarin Red-S for examining mineralization, alkaline phosphatase activity 
measurement, and real-time gene expression analyses of collagen 1 (COL1), collagen 
2 (COL2), adiponectin (ADIPOQ), fatty acid binding protein 4 (FABP4), runt-related 
transcription factor 2 (RUNX2) and transcription factor SOX-9 (SOX9) as 
adipogenic, chondrogenic and osteogenic markers. 
 
3.3.1 ANALYSIS OF CALCIUM DEPOSITION AND MINERALIZATION 
 
 First of all, we investigated the osteogenic differentiation of the rat 
mesenchymal stem cells with Alizarin Red-S staining. Alizarin Red-S, sodium 
alizarin sulfonate, is the salt of alizarin and it is a specific reagent for calcium when it 
is used at pH 4.1 to pH 4.3 
99
. Alizarin Red-S staining has been used for decades to 
selectively examine calcium-rich deposits formed by cells in culture 
100
. In this study, 
we used Alizarin Red-S staining to qualitatively and quantitatively analyze the 
differentiation fate of rat mesenchymal stem cells towards osteogenic lineage. We 
used different peptide nanofiber networks which were deliberatively formed as they 
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contained glucose residue with sulfonate and/or carboxylate residues in different 
ratios. The peptide nanofiber networks used in this investigation were Glc-PA/E-PA, 
Glc-PA/SO3-PA, Glc-PA/SO3-PA/E-PA and K-PA/E-PA. Tissue culture plate was 
also used to observe what happened to the cells over non-coated surfaces. Two 
different media were used in the experiments which were growth medium and 
osteogenic differentiation medium. Osteogenic differentiation medium was typically 
composed of growth medium with additional dexamethasone, β-glycerophosphate 
and ascorbic acid or ascorbic acid analog. It was shown in many studies that 
mesenchymal stem cells can be induced to differentiate into osteoblasts by using 
glucocorticoids 
101-103
. Dexamethasone is a synthetic corticosteroid and supports 
osteogenic differentiation 
104
. We observed deposition of calcium ions in the 
mineralized matrix as in red color under light microscopy. We also performed 
Alizarin Red-S staining over peptide coated wells which did not contain cells to 
check whether non-specific staining occurred or not. We observed little no staining, 
which was negligible when compared to cell containing groups. We observed the 
difference in calcium accumulation when we used osteogenic induction medium at 
day 7 and day 14. Mineralization was induced in all groups when osteogenic 
differentiation medium was used. However, mineralization over Glc-PA/E-PA and 
K-PA/E-PA nanofiber networks increase more than other groups. 
 Overall, we showed that rMSCs seeded over Glc-PA/E-PA, Glc-PA/SO3-
PA/E-PA and K-PA/E-PA nanofiber networks started to accumulate calcium deposits 
which is an indicator for osteogenic differentiation. However, there was no 
significant calcium deposition over Glc-PA/SO3-PA network and TCP. The presence 
of glucose residue in the nanofiber networks induces the calcium deposition and 
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therefore osteogenic differentiation of the rMSCs. Carboxylate-to-glucose ratio is 
also crucial and can be used to direct these cells into osteogenic lineage.  
 
 
Figure 3.10 Alizarin Red-S calcium staining of cells cultured with growth medium at 
day 7. (A) Glc-PA/E-PA, (B) Glc-PA/SO3-PA, (C) Glc-PA/SO3-PA/E-PA, (D) K-
PA/E-PA, (E) TCP and (F) Quantitative analyses of Alizarin Red-S. One-way 
ANOVA with Tukey post test was applied to analyze the results and significant 
differences were expressed as (** p<0.01 and *** p < 0.001). (Scale bars = 200 μm) 
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Figure 3.11 Alizarin Red-S calcium staining of cells cultured with osteogenic 
medium at day 7. (A) Glc-PA/E-PA, (B) Glc-PA/SO3-PA, (C) Glc-PA/SO3-PA/E-
PA, (D) K-PA/E-PA, (E) TCP and (F) Quantitative analyses of Alizarin Red-S. One-
way ANOVA with Tukey post test was applied to analyze the results and significant 
differences were expressed as (* p<0.05, ** p<0.01 and *** p < 0.001). (Scale bars = 
200 μm) 
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Figure 3.12 Alizarin Red-S calcium staining of cells cultured with growth medium at 
day 14. (A) Glc-PA/E-PA, (B) Glc-PA/SO3-PA, (C) Glc-PA/SO3-PA/E-PA, (D) K-
PA/E-PA, (E) TCP and (F) Quantitative analyses of Alizarin Red-S. One-way 
ANOVA with Tukey post test was applied to analyze the results and significant 
differences (**) were expressed at p < 0.01. (Scale bars = 200 μm) 
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Figure 3.13 Alizarin Red-S calcium staining of cells cultured with osteogenic 
medium at day 14. (A) Glc-PA/E-PA, (B) Glc-PA/SO3-PA, (C) Glc-PA/SO3-PA/E-
PA, (D) K-PA/E-PA, (E) TCP and (F) Quantitative analyses of Alizarin Red-S. One-
way ANOVA with Tukey post test was applied to analyze the results and significant 
differences were expressed as (* p<0.05 and ** p<0.01). (Scale bars = 200 μm) 
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Figure 3.14 Alizarin Red-S calcium staining of growth medium without cells at day 
7, conducted as a control for non-specific calcium deposition. (A) Glc-PA/E-PA, (B) 
Glc-PA/SO3-PA, (C) Glc-PA/SO3-PA/E-PA, (D) K-PA/E-PA and (E) TCP. (Scale 
bars = 200 μm) 
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Figure 3.15 Alizarin Red-S calcium staining of osteogenic differentiation medium 
without cells at day 7, conducted as a control for non-specific calcium deposition. 
(A) Glc-PA/E-PA, (B) Glc-PA/SO3-PA, (C) Glc-PA/SO3-PA/E-PA, (D) K-PA/E-PA 
and (E) TCP. (Scale bars = 200 μm) 
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Figure 3.16 Alizarin Red-S calcium staining of growth medium without cells at day 
14, conducted as a control for non-specific calcium deposition. (A) Glc-PA/E-PA, 
(B) Glc-PA/SO3-PA, (C) Glc-PA/SO3-PA/E-PA, (D) K-PA/E-PA and (E) TCP. 
(Scale bars = 200 μm) 
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Figure 3.17 Alizarin Red-S calcium staining of osteogenic differentiation medium 
without cells at day 14, conducted as a control for non-specific calcium deposition. 
(A) Glc-PA/E-PA, (B) Glc-PA/SO3-PA, (C) Glc-PA/SO3-PA/E-PA, (D) K-PA/E-PA 
and (E) TCP. (Scale bars = 200 μm) 
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3.3.2 ALKALINE PHOSPHATASE ACTIVITY 
 
 Alkaline phosphatase activities of the cells seeded over different bio-
functionalized nanofibrous networks were investigated for further characterization of 
the osteogenic differentiation of the rMSCs. Alkaline phosphatase (ALP) is a 
hydrolase enzyme which is responsible for the removal of phosphate groups from 
many types of molecules to produce inorganic phosphate 
105
. It is demonstrated that 
it can be used in mineralization process 
106
. It was also shown that alkaline 
phosphatase activity present in 3T3-L1 cells 
107
. In another study, the relationship 
between ALP activity and cellular lipid accumulation in both human preadipocytes 
and 3T3-L1 cells was investigated by using Pearson correlation. It was demonstrated 
that there was a very strong positive correlation between ALP activity and 
intracellular lipid accumulation and therefore it was concluded that ALP activity can 
also be used as an indicator of intracellular lipid accumulation 
108
. In a previous 
study, ALP activity was also shown in the plasma membrane of multivacuolar 
preadipocytes. They also demonstrated the correlation between ALP activity and size 
of preadipocytes and showed strong ALP activity in smaller preadipocytes, moderate 
ALP activity in intermediate sized preadipocytes and no ALP activity in unicellular 
mature fat cells and also in preadipocytes exceeding 120 μm in largest diameter 109. 
In this study, we tried to analyze the alkaline phosphatase activities of rat 
mesenchymal stem cells seeded over different peptide nanofiber networks and 
uncoated tissue culture plate. The peptide nanofiber networks used in this 
investigation were Glc-PA/E-PA, Glc-PA/SO3-PA, Glc-PA/SO3-PA/E-PA and K-
PA/E-PA. ALP activities of the rMSCs were checked at day 3 and day 7, when the 
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cells were cultured with growth medium and osteogenic differentiation medium. To 
investigate ALP activity, protein extraction was performed to obtain whole protein 
samples from the cells. The protein concentrations of the cells were acquired from 
coupling of the absorbance values obtained from a microplate reader at 562 nm with 
the standard curve constituted by using known BSA standard (Figure 3.22). We also 
formed a standard curve by using p-nitrophenol (Figure 3.23) and used this curve to 
calculate the ALP activities of the rMSCs seeded over different microenvironments. 
We observed an increase in ALP activities of the cells seeded on Glc-PA/SO3-PA 
and Glc-PA/SO3-PA/E-PA nanofiber networks both at day 3 and day 7 compared to 
other nanofiber networks and uncoated tissue culture plate. We observed enhanced 
ALP activity from day 3 to day 7, and therefore, we concluded that adipogenic 
differentiation of the rMSCs proceeded through this time period. 
 To sum up, it was shown that rMSCs seeded over Glc-PA/SO3-PA and Glc-
PA/SO3-PA/E-PA nanofiber networks exhibited higher ALP activities when 
compared to other groups. This increase in the ALP activity can be explained with 
the facts in literature which demonstrated enhancement in the ALP activity in the 
adipocytes. We did not observe any significant differences between Glc-PA/E-PA 
and K-PA/E-PA nanofiber networks and this might be explained with the ALP 
activities due to osteogenic differentiation of the cells over these peptidic scaffolds 
and Ca
2+
 deposition. ALP activity on the Glc-PA/SO3-PA/E-PA network also might 
be caused by the dual effects of adipogenic and osteogenic differentiation of the 
rMSCs over this nanofiber network. 
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Figure 3.18 p-nitrophenol standard curve obtained by using known p-nitrophenol 
standards. The standard curve was used to analyze the ALP activities of the rMSCs. 
The slope of the best line was 0.0723. 
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Figure 3.19 Alkaline phosphatase activity of rat mesenchymal stem cells at day 3. 
Different nanofiber networks were used to investigate the changes in ALP activity 
according to the bio-functionality of the microenvironment. ALP activity of the 
rMSCs roughly correspond to the lipid accumulation characteristics of these cells. 
One-way ANOVA with Tukey post test was applied to analyze the results and 
significant differences were expressed as (* p<0.05, ** p<0.01 and *** p < 0.001). 
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Figure 3.20 Alkaline phosphatase activity of rat mesenchymal stem cells at day 7. 
Different nanofiber networks were used to investigate the changes in ALP activity 
according to the bio-functionality of the microenvironment. ALP activity of the 
rMSCs roughly correspond to the lipid accumulation characteristics of these cells. 
One-way ANOVA with Tukey post test was applied to analyze the results and 
significant differences were expressed as (* p<0.05, ** p<0.01 and *** p < 0.001). 
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3.3.3 EXPRESSION LEVELS OF OSTEOGENIC DIFFERENTIATION 
MARKERS 
 
 Gene expression profiles of rat mesenchymal stem cells cultured on peptide 
nanofiber networks coated and uncoated surfaces were analyzed in order to 
understand differential effects of various peptide nanofiber systems on the 
differentiation fate of the cells towards osteogenic lineage. Expression levels of two 
different genes were investigated for understanding differentiation fates of rat 
mesenchymal stem cells seeded over various peptide nanofiber networks. These 
genes were collagen 1 (COL1) and runt-related transcription factor 2. COL1 and 
RUNX2 expression were investigated to understand osteogenic differentiation of rat 
mesenchymal stem cells. These gene were examined at day 7 and day 14 when 
rMSCs were cultured with growth medium and osteogenic differentiation medium. 
COL1 expression level increases during osteogenic differentiation of mesenchymal 
stem cells 
110
. In one study, it was demonstrated that discoidin domain receptor 1, a 
collagen activated receptor tyrosine kinase, took roles in the stem cell response to 
and interaction with three dimensional type I collagen, and the inhibition of this 
receptor caused a decrease in the osteogenic differentiation of the stem cells 
111
. 
RUNX2 plays a crucial role in bone development and early stage of osteogenic 
differentiation of the pluripotent mesenchymal cells 
112
. In this experiment, we 
observed that the expression levels of RUNX2 gene increased in the cells seeded 
over Glc-PA/E-PA and K-PA/E-PA networks due to osteochondral differentiation. 
However, it was still not enough for the cells to differentiate towards osteogenic 
lineage, and therefore the expression levels of COL1 gene, which directly correlate 
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with the RUNX2 expression level, did not enhance in all groups. In the experiments 
in which osteogenic medium was used, it was demonstrated cells responses to the 
microenvironment also changed according to their culturing conditions.  
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Figure 3.21 Gene expression analyses of rat mesenchymal stem cells cultured on 
various nanofiber networks and tissue culture plate with growth medium at day 7. 
(A) RUNX2 and (B) COL1. The expression level of each gene was normalized 
against TCP and GAPDH, the latter of which was used as internal control. 
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Figure 3.22 Gene expression analyses of rat mesenchymal stem cells cultured on 
various nanofiber networks and tissue culture plate with growth medium at day 14. 
(A) RUNX2 and (B) COL1. The expression level of each gene was normalized 
against TCP and GAPDH, the latter of which was used as internal control. 
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Figure 3.23 Gene expression analyses of rat mesenchymal stem cells cultured on 
various nanofiber networks and tissue culture plate with osteogenic differentiation 
medium at day 7. (A) RUNX2 and (B) COL1. The expression level of each gene was 
normalized against TCP and GAPDH, the latter of which was used as internal 
control. One-way ANOVA with Tukey post test was applied to analyze the results 
and significant differences were expressed as (** p<0.01 and *** p<0.001). 
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Figure 3.24 Gene expression analyses of rat mesenchymal stem cells cultured on 
various nanofiber networks and tissue culture plate with osteogenic differentiation 
medium at day 14. (A) RUNX2 and (B) COL1. The expression level of each gene 
was normalized against TCP and GAPDH, the latter of which was used as internal 
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control. One-way ANOVA with Tukey post test was applied to analyze the results 
and significant differences were expressed as (* p<0.05 and ** p<0.01). 
 Overall, osteogenic differentiation analyses showed that cells were induced to 
differentiate into osteogenic lineage more in the absence of sulfonate groups and 
presence of carboxylate groups, however, the qRT-PCR analyses results were not in 
correlation with alkaline phosphatase activity assay results. Since ALP activity is 
also increased during adipogenic differentiation, we further analyzed the cells for 
adipogenic activity. 
 
3.3.4 NEUTRAL TRIGLYCERIDE AND LIPID PRODUCTION ANALYSES 
 
 Oil Red-O staining was performed in order to visualize neutral triglycerides 
and lipids accumulations by rMSCs on different peptide nanofiber networks and 
uncoated tissue culture plate. We analyzed the neutral triglyceride and lipid 
depositions in cells cultured by using growth medium over functionalized nanofiber 
networks. Oil Red-O, which is a fat soluble diazol dye, stains neutral lipids and 
cholesteryl esters. It gives a maximum absorption at 518 nm and does not stain 
biological membranes 
113
. The positive effect of glucose residues was observed on 
the accumulation of neutral lipid vacuoles, which is a sign of adipogenic 
differentiation. Furthermore, it was quantitatively demonstrated that the 
incorporation of sulfonate residues and carboxylate residues into the these 
functionalized platforms also contributed to adipogenic differentiation. We did not 
observed any significant difference in adipogenic differentiation between K-PA/E-
PA nanofiber network and un-coated tissue culture plate which also supported this 
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conclusion. In one study, it was demonstrated that heparin can be used to promote 
adipocyte differentiation due to its dose dependent inhibitory effects on 
differentiation of osteoblast in vitro and inhibitory effects on the formation of bone in 
vivo 
114-115
. In accordance with these reports, lipid accumulation started from day 7 
over Glc-PA/SO3-PA and Glc-PA/SO3-PA/E-PA nanofiber networks in which 
osteogenic differentiation of the rat mesenchymal stem cells were diminished. We 
did not observe any lipid accumulation over K-PA/E-PA nanofiber network and un-
coated tissue culture plates perhaps because these experimental groups did not 
contain enough functionalization which support adipogenic differentiation. We also 
observed that the significant difference between Glc-PA/SO3-PA nanofiber network 
and TCP and Glc-PA/SO3-PA/E-PA nanofiber network and TCP increased from day 
7 to day 14, which was an indicator for the continuum of adipogenic differentiation.
 To conclude, we found out that the nanofiber networks that formed from 
sulfonate residue containing peptide amphiphile molecules supported adipogenic 
differentiation of rMSCs cultured with growth medium. Furthermore, we also 
demonstrated that presence of glucose group in the microenvironment also supported 
the adipogenic differentiation of rMSCs however presence of sulfate group in the 
microenvironment started this differentiation earlier. We did not observe any lipid 
accumulation over K-PA/E-PA nanofiber network and uncoated tissue culture plate 
and therefore concluded that presence of glucose residue is the primary requirement 
for the adipogenic differentiation over our bio-functionalized nanofiber platforms. 
 
3.3.5 EXPRESSION LEVELS OF ADIPOGENIC DIFFERENTIATION 
MARKERS 
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 Subsequent to lipid accumulation analyses with Oil Red-O staining, gene 
expression profiles of rat mesenchymal stem cells cultured on peptide nanofiber 
network coated and uncoated surfaces were further analyzed in order to understand 
differential effects of various peptide nanofiber systems on the differentiation fate of 
the cells towards adipogenic lineage. Expression levels of two different genes were 
investigated for understanding differentiation fates of rMSCs seeded over various 
peptide nanofiber networks. These genes were adiponectin (ADIPOQ) and fatty acid 
binding protein 4 (FABP4). These gene were examined at day 7 and day 14 when 
rMSCs were cultured with growth medium. Fatty acid binding proteins are a family 
of lipid binding transport proteins and they take roles in the regulation of fatty acid 
uptake and intracellular transport 
124
. FABP4 which is also known as adipocyte 
protein 2 is the member of this family that is primarily expressed in adipocytes and 
macrophages 
125
. Expression levels of FABP4 and ADIPOQ increase during the late 
stage of adipogenic differentiation 
126
. In these experiments, the effects of glucose 
and sulfonate residues on the adipogenic differentiation of rMSCs were also 
illustrated at gene level by analyzing the expression levels of adiponectin and fatty 
acid binding protein 4 genes. The expression levels of both ADIPOQ and FABP4 
were enhanced at day 7 and day 14 by the cells seeded over Glc-PA/E-PA, Glc-
PA/SO3-PA and Glc-PA/SO3-PA/E-PA nanofiber networks and these increases in the 
gene expressions were related with the adipogenic differentiation of the rMSCs. The 
presence of glucose residue in the microenvironment had positive effect on the 
differentiation of rat mesenchymal stem cells. However, the presence of sulfonate 
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residue in the nanofibrous networks  is also important and has positive effect on the 
lipid accumulation and adipogenic differentiation of the rat mesenchymal stem cells. 
 
Figure 3.25 Oil Red-O staining of cells in growth medium at day 7, showing the 
extent of lipid deposition. (A) Glc-PA/E-PA, (B) Glc-PA/SO3-PA, (C) Glc-PA/SO3-
PA/E-PA, (D) K-PA/E-PA, (E) TCP and (F) Quantification of Oil Red O. One-way 
ANOVA with Tukey post test was applied to analyze the results and significant 
differences were expressed as (* p<0.05 and ** p<0.01). (Scale bars = 200 μm) 
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Figure 3.26 Oil Red-O staining of cells in growth medium at day 14, showing the 
extent of lipid deposition. (A) Glc-PA/E-PA, (B) Glc-PA/SO3-PA, (C) Glc-PA/SO3-
PA/E-PA, (D) K-PA/E-PA, (E) TCP and (F) Quantification of Oil Red O. One-way 
ANOVA with Tukey post test was applied to analyze the results and significant 
differences were expressed as (** p<0.01 and *** p<0.001). (Scale bars = 200 μm) 
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Figure 3.27 Gene expression analyses of rat mesenchymal stem cells cultured on 
various nanofiber networks and tissue culture plate with growth medium at day 7. 
(A) FABP4 and (B) ADIPOQ. The expression level of each gene was normalized 
against TCP and GAPDH, the latter of which was used as internal control. One-way 
ANOVA with Tukey post test was applied to analyze the results and significant 
differences were expressed as (* p<0.05 and ** p<0.01). 
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Figure 3.28 Gene expression analyses of rat mesenchymal stem cells cultured on 
various nanofiber networks and tissue culture plate with growth medium at day 14. 
(A) FABP4 and (B) ADIPOQ. The expression level of each gene was normalized 
against TCP and GAPDH, the latter of which was used as internal control. 
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 Overall, the adipogenic and osteogenic differentiation analyses showed that 
cells were induced to differentiate into adipogenic lineage in the presence of 
sulfonate groups and more to the osteogenic lineage in the absense of sulfonate 
groups in growth medium. Osteogenic differentiation of mesenchymal stem cells is 
strongly correlated with chondrogenic differentiation and these two pathways are 
altogether known as osteochondrogenic differentiation. Thus, we further analyzed the 
cells for the presence or absence of chondrogenic markers.   
 
3.3.6 SULFATED GLYCOSAMINOGLYCAN PRODUCTION ANALYSES 
 
 Finally, safranin-O staining was performed to investigate the chondrogenic 
differentiation of the cells, the last remaining mesodermal lineage that mesenchymal 
stem cells can also differentiate. It was used in order to visualize sulfated 
glycosaminoglycan accumulation by rMSCs that were seeded over different peptide 
nanofiber networks and uncoated tissue culture plate. Safranin-O staining has been 
used for many decades for the detection of articular cartilage formation 
116
. Safranin-
O is a cationic dye that binds to sulfated glycosaminoglycans specifically and 
stochiometrically 
117
. Therefore, secreted cartilaginous extracellular matrix can be 
indexed by Safranin-O staining and the intensity of staining is directly proportional 
to the glycosaminoglycan content. In this study, we analyzed the sulfated 
glycosaminoglycan depositions on peptide nanofiber networks at day 7 and day 14 
when the cells cultured by using growth medium.  
 Nodule like structures were observed over Glc-PA/E-PA and K-PA/E-PA 
nanofiber networks at day 7 which were indicators of chondrogenic differentiation of 
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the mesenchymal stem cells (Figure 3.18). We also observed formation of small 
nodule like structures over Glc-PA/SO3-PA/E-PA nanofiber network at day 14 in 
addition to Glc-PA/E-PA and K-PA/E-PA nanofiber networks. For each 
experimental day (Day 7 and Day 14), we did not observe any cell aggregation which 
showed resemblance to cartilage formation and positive Safranin-O staining over 
Glc-PA/SO3-PA nanofiber network. Glc-PA/E-PA network system mimic 
hyaluronan. During embryonic cartilage development, hyaluronan can be found in 
high amounts in the ECM of the cells and it also takes roles in and assist the 
integration of engineered cartilage tissues 
118
. Therefore cells seeded over this 
scaffold had a tendency towards chondrogenic lineage. We also observed nodule-like 
structures over K-PA/E-PA nanofiber network and this could be explained due to 
structural similarity between this network and Glc-PA/E-PA network. We analyzed 
small nodule-like structures over Glc-PA/SO3-PA/E-PA nanofiber network in 
Safranin-O staining at day 14. We thought this functionalized network system 
resembled chondroitin sulfate glycosaminoglycan. In a study, it was shown that 
integration of chondroitin sulfate into scaffold may promote secretion of collagen 2 
and proteoglycans 
119
. In another research, it was also demonstrated that bone 
marrow derived mesenchymal stem cells in chondroitin sulfate based bioactive 
hydrogels aggregated in such a way that produced cartilaginous tissues 
120
. On Glc-
PA/SO3-PA nanofiber network and uncoated tissue culture plate, we did not observe 
any Safranin-O staining and concluded that there was no chondrogenesis over these 
groups. Thus, elevated sulfonate residues per glucose levels in the nanofiber network 
platform might cause a decrease in the differentiation of rMSCs towards 
chondrogenic lineage. 
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 To sum up, Glc-PA/E-PA and K-PA/E-PA nanofiber networks supported 
chondrogenic differentiation starting from day 7 and continued this support still at 
the end of day 14. While over Glc-PA/SO3-PA/E-PA nanofiber network, 
differentiation of rMSCs toward chondrogenic lineage was only observed at the end 
of day 14, in which we concluded that over Glc-PA/E-PA and K-PA/E-PA nanofiber 
networks chondrogenic differentiation was enhanced compared to Glc-PA/SO3-
PA/E-PA bioactive scaffold. Finally, we did not observe any differentiation towards 
chondrogenic lineage on Glc-PA/SO3-PA and uncoated tissue culture plate. 
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Figure 3.29 Safranin-O staining at day 7 for the analysis of sulfated 
glycosaminoglycan incorporation. Cells were cultured with growth medium. (A) Glc-
PA/E-PA, (B) Glc-PA/SO3-PA, (C) Glc-PA/SO3-PA/E-PA, (D) K-PA/E-PA and (E) 
TCP. (Scale bars = 200 μm) 
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Figure 3.30 Safranin-O staining at of cells in growth medium at day 7, showing the 
extent of sulfated glycosaminoglycan incorporation. (A) Glc-PA/E-PA, (B) Glc-
PA/SO3-PA, (C) Glc-PA/SO3-PA/E-PA, (D) K-PA/E-PA and (E) TCP. (Scale bars = 
200 μm) 
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3.3.7 EXPRESSION LEVELS OF CHONDROGENIC DIFFERENTIATION 
MARKERS 
 
 Following to sulfated glycosaminoglycan deposition analyses with safranin-O 
staining, gene expression profiles of rMCSs cultured on peptide nanofiber network 
coated and uncoated surfaces were analyzed in order to further investigate the 
differentiation potential of the cells towards chondrogenic lineage. Expression levels 
of two different genes were investigated for understanding differentiation fates of 
rMSCs seeded over various peptide nanofiber networks towards chondrogenic 
lineage. These genes were collagen 2 (COL2) and transcription factor SOX-9 
(SOX9). COL2 and SOX9 expression were analyzed to understand chondrogenic 
differentiation of rMSCs. Collagens, a multigene family, are structural proteins found 
in the extracellular matrix 
121
. COL2/COL1 ratio decreases during the late phase of 
chondrogenic differentiation which means expression level of collagen 1 starts to 
increase compared to collagen 2 expression level 
122
. Increase in the expression level 
of SOX9 is correlated to a high expression of collagen 2 in mesenchymal stem cells 
123
. It was shown that the expression level of SOX9 gene increased at day 7 in the 
cells seeded over Glc-PA/E-PA and K-PA/E-PA nanofiber networks and the 
expression level of COL1 gene increased at day 14 in the cells seeded over Glc-
PA/E-PA nanofiber network. These results were related with the early stage of 
chondrogenic differentiation in which SOX9 expression starts to increase and 
induces COL2 expression for fully differentiation. qRT-PCR analyses of these 
markers and osteogenic markers demonstrated that rMSCs seeded on Glc-PA/E-PA 
84 
 
and K-PA/E-PA networks started to differentiate by using osteochondral 
differentiation pathway. 
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Figure 3.31 Gene expression analyses of rat mesenchymal stem cells cultured on 
various nanofiber networks and tissue culture plate with growth medium at day 7. 
(A) SOX9 and (B) COL2. The expression level of each gene was normalized against 
TCP and GAPDH, the latter of which was used as internal control. 
G
E
G
S
G
E
S
K
E
T
C
P
0.0
0.5
1.0
1.5
**
**
*
*
*
*
R
e
la
ti
v
e
 G
e
n
e
 E
x
p
re
s
s
io
n
(N
o
rm
a
liz
e
d
 t
o
 T
C
P
)
G
E
G
S
G
E
S
K
E
T
C
P
0.0
0.5
1.0
1.5
2.0
2.5
*
R
e
la
ti
v
e
 G
e
n
e
 E
x
p
r
e
ss
io
n
(N
o
r
m
a
li
ze
d
 t
o
 T
C
P
)
(A) (B)
 
Figure 3.32 Gene expression analyses of rat mesenchymal stem cells cultured on 
various nanofiber networks and tissue culture plate with growth medium at day 14. 
(A) SOX9 and (B) COL2. The expression level of each gene was normalized against 
TCP and GAPDH, the latter of which was used as internal control. One-way 
ANOVA with Tukey post test was applied to analyze the results and significant 
differences were expressed as (* p<0.05 and ** p<0.01). 
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CHAPTER 4 
CONCLUSION AND FUTURE PERSPECTIVES 
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 The microenvironment of the cells is composed of various fibrous proteins 
and glycosaminoglycans in the form of proteoglycans. It is crucial to mimic the 
glycosaminoglycan content of the extracellular matrix to control the differentiation 
fate of the mesenchymal stem cells. Peptide amphiphile molecules provide good 
opportunities to mimic the native ECM microenvironments of the cells. They can 
form long nanofibrous networks due to their self-assembly properties and can be 
modified with various biological signals to mimic ECM of different tissue types. 
 In this study, we tried to form glycosaminoglycan mimetic nanofibrous 
networks by using four different peptide amphiphile molecules. These peptide 
amphiphile molecules contained different chemical groups including glucose, 
sulfonate and carboxylate on their peptide backbone. We controlled the amount of 
chemical groups in the microenvironment by changing the concentration of the 
molecules. By this way, we constituted different ECM mimetic systems where we 
tested the changes in the differentiation potentials of the rat mesenchymal stem cells. 
We demonstrated that when the degree of sulfonation increased in the nanofibrous 
networks, the rat mesenchymal stem cells started to differentiate towards adipogenic 
lineage and when the degree of carboxylation increased in the nanofibrous networks, 
the cells started to differentiate towards osteochondrogenic lineages. We also 
demonstrated that the presence of glucose residues in the microenvironment as 
attached to the peptide nanofibers drastically decreases the proliferation of rat 
mesenchymal stem cells and perhaps contributes to the specialization and 
differentiation of these cells. 
 Overall, this study offers a general strategy for the development of functional 
peptide nanofiber platforms for mimicking sulfated and non-sulfated natural 
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glycosaminoglycans. It was demonstrated that well ordered peptidic nanostructures 
can be formed by using various self-assembled nanofibers which were formed by 
using bottom-up design strategy. It was also shown that the content of the nanofiber 
networks can be controlled according to the demand and application of interests. As 
a future perspective, differentiation of the rat mesenchymal stem cells can be further 
characterized by using flow cytometry. With this technique, we can quantify the 
percentage of differentiated cells in the nanofibrous microenvironments by labeling 
specific surface markers of the cells according to their differentiation states. The 
effects of glucose, sulfonate or carboxylate residue containing peptide amphiphile 
molecules on the differentiation fates of rat mesenchymal stem cells can be also 
examined by supplying these molecules as a soluble factor when the cells are seeded 
over non-bioactive scaffolds. With this experiment, we can test the response of the 
cells when their surroundings are saturated with a specific differentiation signal. We 
can further analyze the differentiation pathways activated in mesenchymal stem cells 
by these peptide nanofiber networks with surface receptor blocking experiments. The 
amounts of calcium, lipid and/or sulfated glycosaminoglycan depositions can also be 
adjusted to the DNA concentration in the microenvironments for obtaining more 
accurate and specific differentiation results. The differentiation diversities of the rat 
mesenchymal stem cells even in the same microenvironment can be demonstrated 
with immunocytochemistry. Finally, the efficiency of cell differentiation and future 
success of these functionalized platforms can be tested and evaluated with an in vivo 
study and further translated into clinical studies. 
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